<!DOCTYPE html>
<html><head><meta charset="UTF-8">
<title>Earnings Call ë²ˆì—­</title>
<style>
    body { font-family: Arial; margin: 40px; background-color: #fdfdfd; }
    h1 { text-align: center; }
    h2 { margin-top: 50px; color: #003366; }
    h3 { color: #333; }
    table { border: 1px solid #ddd; width: 100%; border-collapse: collapse; }
    th { background: #f0f0f0; padding: 10px; border-bottom: 2px solid #ccc; }
    td { padding: 10px; border-bottom: 1px dotted #ccc; vertical-align: top; }
    p { line-height: 1.6; }
    hr { margin: 50px 0; border: none; border-top: 1px solid #ccc; }
    .back-button {
        display: inline-block;
        background-color: #5f5f5f;
        color: white;
        padding: 10px 16px;
        border-radius: 6px;
        text-decoration: none;
        font-weight: 500;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
        margin-bottom: 30px;
    }
</style>
</head><body>
<a href="../../index.html" class="back-button">â†</a>
<h1>ğŸ“„ Earnings Call Transcript ë²ˆì—­ ê²°ê³¼</h1>

    <h2>ğŸ“Š Presentation</h2>
    <table style="width:100%; border-collapse:collapse; margin-bottom: 40px;">
        <tr>
            <th style="width:50%; border-bottom: 2px solid #333;">Original</th>
            <th style="width:50%; border-bottom: 2px solid #333;">Translation</th>
        </tr>
        <tr><td>Phreesia, Inc.</td><td># í”„ë¦¬ì§€ì•„(Phreesia, Inc.)<br><br>**2024ë…„ 4ë¶„ê¸° ì‹¤ì  ë°œí‘œ ì»¨í¼ëŸ°ìŠ¤ ì½œ ë²ˆì—­**<br><br>---<br><br>**íšŒì‚¬ ì°¸ì„ì:**<br>- ë°œë Œ ìì¹´ë¦¬ì•ˆ(Balint Szekeres) - íˆ¬ìì ê´€ê³„ ë‹´ë‹¹ ë¶€ì‚¬ì¥<br>- ì±„ë“œ ë ˆì´ë†€ì¦ˆ(Chaim Indig) - ìµœê³ ê²½ì˜ì(CEO)<br>- ëœë”” ë¼ë¹„ì¹˜(Randy Rasmussen) - ìµœê³ ì¬ë¬´ì±…ì„ì(CFO)<br><br>---<br><br>**ë°œë Œ ìì¹´ë¦¬ì•ˆ:**<br><br>ì•ˆë…•í•˜ì‹­ë‹ˆê¹Œ. í”„ë¦¬ì§€ì•„ì˜ 2024 íšŒê³„ì—°ë„ 4ë¶„ê¸° ì‹¤ì  ë°œí‘œ ì»¨í¼ëŸ°ìŠ¤ ì½œì— ì˜¤ì‹  ê²ƒì„ í™˜ì˜í•©ë‹ˆë‹¤. ì €ëŠ” íˆ¬ìì ê´€ê³„ ë‹´ë‹¹ ë¶€ì‚¬ì¥ ë°œë Œ ìì¹´ë¦¬ì•ˆì…ë‹ˆë‹¤. ì˜¤ëŠ˜ ì €ì™€ í•¨ê»˜ ìµœê³ ê²½ì˜ì ì±„ë“œ ë ˆì´ë†€ì¦ˆì™€ ìµœê³ ì¬ë¬´ì±…ì„ì ëœë”” ë¼ë¹„ì¹˜ê°€ ì°¸ì„í–ˆìŠµë‹ˆë‹¤.<br><br>ì˜¤ëŠ˜ ì»¨í¼ëŸ°ìŠ¤ ì½œì—ì„œ ê²½ì˜ì§„ì€ ë¯¸ë˜ì˜ˆì¸¡ì§„ìˆ ì„ í•  ì˜ˆì •ì…ë‹ˆë‹¤. ì´ëŸ¬í•œ ì§„ìˆ ì€ 1995ë…„ ë¯¼ê°„ì¦ê¶Œì†Œì†¡ê°œí˜ë²•ì˜ ì„¸ì´í”„í•˜ë²„ ì¡°í•­ì— ë”°ë¼ ì´ë£¨ì–´ì§‘ë‹ˆë‹¤. ë¯¸ë˜ì˜ˆì¸¡ì§„ìˆ ì—ëŠ” ë‹¹ì‚¬ì˜ ì¬ë¬´ ì „ë§, ì‹œì¥ ê¸°íšŒ, ì œí’ˆ ê°œë°œ ê³„íš ë° ì‚¬ì—… ì „ëµì— ê´€í•œ ì§„ìˆ ì´ í¬í•¨ë˜ë‚˜ ì´ì— êµ­í•œë˜ì§€ ì•ŠìŠµë‹ˆë‹¤.<br><br>ì´ëŸ¬í•œ ë¯¸ë˜ì˜ˆì¸¡ì§„ìˆ ì€ í˜„ì¬ ì…ìˆ˜ ê°€ëŠ¥í•œ ì •ë³´ë¥¼ ê¸°ë°˜ìœ¼ë¡œ í•˜ë©° ìœ„í—˜ê³¼ ë¶ˆí™•ì‹¤ì„±ì„ ìˆ˜ë°˜í•©ë‹ˆë‹¤. ì‹¤ì œ ê²°ê³¼ëŠ” ì´ëŸ¬í•œ ë¯¸ë˜ì˜ˆì¸¡ì§„ìˆ ê³¼ í¬ê²Œ ë‹¤ë¥¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤. ì´ëŸ¬í•œ ìœ„í—˜ì— ëŒ€í•œ ìì„¸í•œ ë‚´ìš©ì€ SECì— ì œì¶œí•œ ì„œë¥˜ë¥¼ ì°¸ì¡°í•˜ì‹œê¸° ë°”ëë‹ˆë‹¤.<br><br>í”„ë¦¬ì§€ì•„ëŠ” ë²•ë¥ ì´ ìš”êµ¬í•˜ëŠ” ê²½ìš°ë¥¼ ì œì™¸í•˜ê³ ëŠ” ë¯¸ë˜ì˜ˆì¸¡ì§„ìˆ ì„ ì—…ë°ì´íŠ¸í•  ì˜ë¬´ê°€ ì—†ìŠµë‹ˆë‹¤. ë˜í•œ ì˜¤ëŠ˜ ë…¼ì˜ì—ì„œëŠ” GAAP ê¸°ì¤€ê³¼ ë¹„GAAP ì¬ë¬´ì§€í‘œë¥¼ ëª¨ë‘ ì°¸ì¡°í•  ì˜ˆì •ì…ë‹ˆë‹¤. ë¹„GAAP ì¬ë¬´ì§€í‘œì™€ ê°€ì¥ ì§ì ‘ì ìœ¼ë¡œ ë¹„êµ ê°€ëŠ¥í•œ GAAP ì§€í‘œì™€ì˜ ì¡°ì •í‘œëŠ” ì˜¤ëŠ˜ ì•„ì¹¨ ë°œí‘œí•œ ë³´ë„ìë£Œì™€ íˆ¬ìì í”„ë ˆì  í…Œì´ì…˜ì—ì„œ í™•ì¸í•˜ì‹¤ ìˆ˜ ìˆìŠµë‹ˆë‹¤.<br><br>ì´ì œ ì±„ë“œì—ê²Œ ë§ˆì´í¬ë¥¼ ë„˜ê¸°ê² ìŠµë‹ˆë‹¤.<br><br>---<br><br>**ì±„ë“œ ë ˆì´ë†€ì¦ˆ:**<br><br>ê°ì‚¬í•©ë‹ˆë‹¤, ë°œë Œ. ê·¸ë¦¬ê³  ì˜¤ëŠ˜ ì»¨í¼ëŸ°ìŠ¤ ì½œì— ì°¸ì—¬í•´ ì£¼ì‹  ëª¨ë“  ë¶„ë“¤ê»˜ ê°ì‚¬ë“œë¦½ë‹ˆë‹¤.<br><br>2024 íšŒê³„ì—°ë„ 4ë¶„ê¸°ëŠ” í”„ë¦¬ì§€ì•„ì—ê²Œ ê°•ë ¥í•œ ë§ˆë¬´ë¦¬ì˜€ìœ¼ë©°, ì—°ê°„ ê¸°ì¤€ìœ¼ë¡œë„ í›Œë¥­í•œ í•œ í•´ì˜€ìŠµë‹ˆë‹¤. 4ë¶„ê¸° ë§¤ì¶œì€ ì „ë…„ ë™ê¸° ëŒ€ë¹„ 21% ì¦ê°€í•œ 9,750ë§Œ ë‹¬ëŸ¬ë¥¼ ê¸°ë¡í–ˆìœ¼ë©°, ì¡°ì • EBITDAëŠ” 1,370ë§Œ ë‹¬ëŸ¬ë¡œ ì „ë…„ ë™ê¸° ëŒ€ë¹„ í¬ê²Œ ê°œì„ ë˜ì—ˆìŠµë‹ˆë‹¤.<br><br>ì „ì²´ íšŒê³„ì—°ë„</td></tr>
<tr><td>(PHR) Q3 2026 Earnings Call December 8, 2025 5:00 PM EST<br><br>Company Participants<br><br>Balaji Gandhi - Chief Financial Officer<br>Chaim Indig - Co-Founder, CEO & Director<br><br>Conference Call Participants<br><br>Sean Dodge - BMO Capital Markets Equity Research<br>Scott Schoenhaus - KeyBanc Capital Markets Inc., Research Division<br>Jailendra Singh - Truist Securities, Inc., Research Division<br>Brian Tanquilut - Jefferies LLC, Research Division<br>Ryan Daniels - William Blair & Company L.L.C., Research Division<br>Ryan MacDonald - Needham & Company, LLC, Research Division<br>Richard Close - Canaccord Genuity Corp., Research Division<br>Daniel Grosslight - Citigroup Inc., Research Division<br>Jeffrey Garro - Stephens Inc., Research Division<br>John Ransom - Raymond James & Associates, Inc., Research Division<br>Jessica Tassan - Piper Sandler & Co., Research Division<br>Joseph Vruwink - Robert W.</td><td># (PHR) 2026ë…„ 3ë¶„ê¸° ì‹¤ì  ë°œí‘œ ì»¨í¼ëŸ°ìŠ¤ ì½œ 2025ë…„ 12ì›” 8ì¼ ì˜¤í›„ 5ì‹œ (ë¯¸êµ­ ë™ë¶€ í‘œì¤€ì‹œ)<br><br>íšŒì‚¬ ì°¸ì„ì<br><br>ë°œë¼ì§€ ê°„ë””(Balaji Gandhi) - ìµœê³ ì¬ë¬´ì±…ì„ì(CFO)<br>ì°¨ì„ ì¸ë””ê·¸(Chaim Indig) - ê³µë™ì°½ì—…ì, ìµœê³ ê²½ì˜ì(CEO) ê²¸ ì´ì‚¬<br><br>ì»¨í¼ëŸ°ìŠ¤ ì½œ ì°¸ì„ ì• ë„ë¦¬ìŠ¤íŠ¸<br><br>ìˆ€ ë‹¤ì§€(Sean Dodge) - BMO ìºí”¼íƒˆ ë§ˆì¼“ ì£¼ì‹ ë¦¬ì„œì¹˜<br>ìŠ¤ì½§ ì‡¤í•˜ìš°ìŠ¤(Scott Schoenhaus) - í‚¤ë±…í¬ ìºí”¼íƒˆ ë§ˆì¼“, ë¦¬ì„œì¹˜ ë¶€ë¬¸<br>ìì¼ë Œë“œë¼ ì‹±(Jailendra Singh) - íŠ¸ë£¨ì´ìŠ¤íŠ¸ ì‹œíë¦¬í‹°ì¦ˆ, ë¦¬ì„œì¹˜ ë¶€ë¬¸<br>ë¸Œë¼ì´ì–¸ íƒ„í€¼ëŸ¿(Brian Tanquilut) - ì œí”„ë¦¬ìŠ¤ LLC, ë¦¬ì„œì¹˜ ë¶€ë¬¸<br>ë¼ì´ì–¸ ë‹¤ë‹ˆì—˜ìŠ¤(Ryan Daniels) - ìœŒë¦¬ì—„ ë¸”ë ˆì–´ ì•¤ ì»´í¼ë‹ˆ LLC, ë¦¬ì„œì¹˜ ë¶€ë¬¸<br>ë¼ì´ì–¸ ë§¥ë„ë‚ ë“œ(Ryan MacDonald) - ë‹ˆë¤ ì•¤ ì»´í¼ë‹ˆ LLC, ë¦¬ì„œì¹˜ ë¶€ë¬¸<br>ë¦¬ì²˜ë“œ í´ë¡œì¦ˆ(Richard Close) - ìºë‚˜ì½”ë“œ ì œë‰´ì´í‹° ì½”í¼ë ˆì´ì…˜, ë¦¬ì„œì¹˜ ë¶€ë¬¸<br>ë‹¤ë‹ˆì—˜ ê·¸ë¡œìŠ¤ë¼ì´íŠ¸(Daniel Grosslight) - ì‹œí‹°ê·¸ë£¹, ë¦¬ì„œì¹˜ ë¶€ë¬¸<br>ì œí”„ë¦¬ ê°€ë¡œ(Jeffrey Garro) - ìŠ¤í‹°ë¸ìŠ¤, ë¦¬ì„œì¹˜ ë¶€ë¬¸<br>ì¡´ ëœì„¬(John Ransom) - ë ˆì´ë¨¼ë“œ ì œì„ìŠ¤ ì•¤ ì–´ì†Œì‹œì—ì´ì¸ , ë¦¬ì„œì¹˜ ë¶€ë¬¸<br>ì œì‹œì¹´ íƒ€ì‚°(Jessica Tassan) - íŒŒì´í¼ ìƒŒë“¤ëŸ¬ ì•¤ ì»´í¼ë‹ˆ, ë¦¬ì„œì¹˜ ë¶€ë¬¸<br>ì¡°ì…‰ ë¸Œë£¨ìœ™í¬(Joseph Vruwink) - ë¡œë²„íŠ¸ W.</td></tr>
<tr><td>Baird & Co. Incorporated, Research Division<br>Clark Wright - D.A. Davidson & Co., Research Division<br><br>Presentation<br><br>Operator<br><br>Ladies and gentlemen, thank you for standing by. My name is Abby, and I will be your conference operator today. At this time, I would like to welcome everyone to the Phreesia Third Quarter Fiscal 2026 Earnings Conference Call. [Operator Instructions] Thank you. And I would now like to turn the conference over to Balaji Gandhi, Chief Financial Officer. You may begin. Balaji Gandhi<br>Chief Financial Officer<br><br>Thank you, operator. Good morning, and welcome to Phreesia's earnings conference call for the third quarter of fiscal 2026, which ended on October 31, 2025.</td><td>ë² ì–´ë“œ ì•¤ ì»´í¼ë‹ˆ ì¸ì½”í¼ë ˆì´í‹°ë“œ, ë¦¬ì„œì¹˜ ë¶€ë¬¸<br>í´ë¼í¬ ë¼ì´íŠ¸ - D.A. ë°ì´ë¹„ìŠ¨ ì•¤ ì»´í¼ë‹ˆ, ë¦¬ì„œì¹˜ ë¶€ë¬¸<br><br>ë°œí‘œ<br><br>ì‚¬íšŒì<br><br>ì‹ ì‚¬ ìˆ™ë…€ ì—¬ëŸ¬ë¶„, ê¸°ë‹¤ë ¤ ì£¼ì…”ì„œ ê°ì‚¬í•©ë‹ˆë‹¤. ì €ëŠ” ì• ë¹„ì´ë©°, ì˜¤ëŠ˜ ì»¨í¼ëŸ°ìŠ¤ ì§„í–‰ì„ ë§¡ê²Œ ë˜ì—ˆìŠµë‹ˆë‹¤. ì´ ì‹œê°„ì— í”„ë¦¬ì§€ì•„(Phreesia) 2026 íšŒê³„ì—°ë„ 3ë¶„ê¸° ì‹¤ì  ì»¨í¼ëŸ°ìŠ¤ ì½œì— ì—¬ëŸ¬ë¶„ì„ í™˜ì˜í•©ë‹ˆë‹¤. [ì‚¬íšŒì ì•ˆë‚´ì‚¬í•­] ê°ì‚¬í•©ë‹ˆë‹¤. ì´ì œ ë°œë¼ì§€ ê°„ë”” ìµœê³ ì¬ë¬´ì±…ì„ìì—ê²Œ íšŒì˜ë¥¼ ë„˜ê¸°ê² ìŠµë‹ˆë‹¤. ì‹œì‘í•˜ì‹œê¸° ë°”ëë‹ˆë‹¤.<br><br>ë°œë¼ì§€ ê°„ë””<br>ìµœê³ ì¬ë¬´ì±…ì„ì<br><br>ê°ì‚¬í•©ë‹ˆë‹¤, ì‚¬íšŒìë‹˜. ì¢‹ì€ ì•„ì¹¨ì…ë‹ˆë‹¤. 2025ë…„ 10ì›” 31ì¼ì— ì¢…ë£Œëœ 2026 íšŒê³„ì—°ë„ 3ë¶„ê¸° í”„ë¦¬ì§€ì•„ ì‹¤ì  ì»¨í¼ëŸ°ìŠ¤ ì½œì— ì˜¤ì‹  ê²ƒì„ í™˜ì˜í•©ë‹ˆë‹¤.</td></tr>
<tr><td>Joining me on today's call is Chaim Indig, our Chief Executive Officer. A more complete discussion of our results can be found in our earnings press release and in our related Form 8-K submission to the SEC, including our quarterly stakeholder letter, both issued after the markets closed today. These documents are available on the Investor Relations section of our website at ir.phreesia.com. As a reminder, today's call is being recorded, and a replay will be available on our Investor Relations website at ir.phreesia.com following the conclusion of the call.</td><td>ì˜¤ëŠ˜ ì»¨í¼ëŸ°ìŠ¤ ì½œì—ëŠ” Chaim Indig ìµœê³ ê²½ì˜ìê°€ í•¨ê»˜ í•˜ê³  ìˆìŠµë‹ˆë‹¤. ë‹¹ì‚¬ì˜ ì‹¤ì ì— ëŒ€í•œ ë³´ë‹¤ ìƒì„¸í•œ ë…¼ì˜ëŠ” ì˜¤ëŠ˜ ì¥ ë§ˆê° í›„ ë°œí‘œëœ ì‹¤ì  ë³´ë„ìë£Œì™€ ë¶„ê¸°ë³„ ì£¼ì£¼ì„œí•œì„ í¬í•¨í•œ SEC ì œì¶œ Form 8-K ë¬¸ì„œì—ì„œ í™•ì¸í•˜ì‹¤ ìˆ˜ ìˆìŠµë‹ˆë‹¤. ì´ ë¬¸ì„œë“¤ì€ ë‹¹ì‚¬ ì›¹ì‚¬ì´íŠ¸ ir.phreesia.comì˜ íˆ¬ìì ê´€ê³„(IR) ì„¹ì…˜ì—ì„œ ì—´ëŒ ê°€ëŠ¥í•©ë‹ˆë‹¤. ì°¸ê³ ë¡œ ì˜¤ëŠ˜ ì»¨í¼ëŸ°ìŠ¤ ì½œì€ ë…¹ìŒë˜ê³  ìˆìœ¼ë©°, ì½œ ì¢…ë£Œ í›„ ir.phreesia.com íˆ¬ìì ê´€ê³„ ì›¹ì‚¬ì´íŠ¸ì—ì„œ ì¬ìƒ(replay)ì´ ê°€ëŠ¥í•©ë‹ˆë‹¤.</td></tr>
<tr><td>During today's call, we may make forward-looking statements, including statements regarding trends, our anticipated growth, our strategies, predictions about our industry and the anticipated performance of our business, including our outlook regarding future financial results and acquisitions. Forward-looking statements are subject to various risks and uncertainties and other factors that may cause our actual results, performance or achievements to differ materially from those described in our forward-looking statements.</td><td>ì˜¤ëŠ˜ ì»¨í¼ëŸ°ìŠ¤ ì½œì—ì„œ ë‹¹ì‚¬ëŠ” íŠ¸ë Œë“œ, ì˜ˆìƒ ì„±ì¥ë¥ , ì „ëµ, ì—…ê³„ ì „ë§, í–¥í›„ ì¬ë¬´ ì‹¤ì  ë° ì¸ìˆ˜í•©ë³‘ ì „ë§ì„ í¬í•¨í•œ ì‚¬ì—… ì„±ê³¼ì— ëŒ€í•œ ì˜ˆì¸¡ ë“± ë¯¸ë˜ì˜ˆì¸¡ì§„ìˆ (forward-looking statements)ì„ í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤. ë¯¸ë˜ì˜ˆì¸¡ì§„ìˆ ì€ ë‹¤ì–‘í•œ ë¦¬ìŠ¤í¬, ë¶ˆí™•ì‹¤ì„± ë° ê¸°íƒ€ ìš”ì¸ë“¤ì˜ ì˜í–¥ì„ ë°›ì„ ìˆ˜ ìˆìœ¼ë©°, ì´ë¡œ ì¸í•´ ì‹¤ì œ ê²°ê³¼, ì„±ê³¼ ë˜ëŠ” ì„±ì·¨ë„ê°€ ë¯¸ë˜ì˜ˆì¸¡ì§„ìˆ ì—ì„œ ì„¤ëª…í•œ ë‚´ìš©ê³¼ ì¤‘ëŒ€í•˜ê²Œ ìƒì´í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.</td></tr>
<tr><td>Such risks are described more fully in our earnings press release, our stakeholder letter and our risk factors included in our SEC filings, including in our quarterly report on Form 10-Q that will be filed with the SEC tomorrow. The forward-looking statements made on this call will be based on our current views and expectations and speak only as of the date on which the statements are made. We undertake no obligation to update and expressly disclaim the obligation to update these forward-looking statements to reflect events or circumstances after the date of this call or to reflect new information or the occurrence of unanticipated events.</td><td>ì´ëŸ¬í•œ ìœ„í—˜ë“¤ì€ ë‹¹ì‚¬ì˜ ì‹¤ì  ë³´ë„ìë£Œ, ì£¼ì£¼ì„œí•œ ë° SEC ì œì¶œ ì„œë¥˜ì— í¬í•¨ëœ ìœ„í—˜ìš”ì¸ì— ë”ìš± ìƒì„¸íˆ ê¸°ìˆ ë˜ì–´ ìˆìœ¼ë©°, ë‚´ì¼ SECì— ì œì¶œë  ë¶„ê¸°ë³´ê³ ì„œ Form 10-Qì—ë„ í¬í•¨ë˜ì–´ ìˆìŠµë‹ˆë‹¤. ë³¸ ì»¨í¼ëŸ°ìŠ¤ ì½œì—ì„œ ì–¸ê¸‰ë˜ëŠ” ë¯¸ë˜ì˜ˆì¸¡ì§„ìˆ ì€ ë‹¹ì‚¬ì˜ í˜„ì¬ ê²¬í•´ì™€ ì˜ˆìƒì— ê¸°ë°˜í•œ ê²ƒì´ë©°, í•´ë‹¹ ì§„ìˆ ì´ ì´ë£¨ì–´ì§„ ë‚ ì§œë¥¼ ê¸°ì¤€ìœ¼ë¡œë§Œ ìœ íš¨í•©ë‹ˆë‹¤. ë‹¹ì‚¬ëŠ” ë³¸ ì»¨í¼ëŸ°ìŠ¤ ì½œ ì´í›„ ë°œìƒí•˜ëŠ” ì‚¬ê±´ì´ë‚˜ ìƒí™©ì„ ë°˜ì˜í•˜ê±°ë‚˜, ìƒˆë¡œìš´ ì •ë³´ ë˜ëŠ” ì˜ˆìƒì¹˜ ëª»í•œ ì‚¬ê±´ì˜ ë°œìƒì„ ë°˜ì˜í•˜ê¸° ìœ„í•´ ì´ëŸ¬í•œ ë¯¸ë˜ì˜ˆì¸¡ì§„ìˆ ì„ ì—…ë°ì´íŠ¸í•  ì˜ë¬´ê°€ ì—†ìœ¼ë©°, ëª…ì‹œì ìœ¼ë¡œ ê·¸ëŸ¬í•œ ì˜ë¬´ë¥¼ ë¶€ì¸í•©ë‹ˆë‹¤.</td></tr>
<tr><td>We may also refer to certain financial measures not in accordance with generally accepted accounting principles, such as adjusted EBITDA and free cash flows in order to provide additional information to investors. These non-GAAP measures should be considered in addition to and not as a substitute for or in isolation from our GAAP results. A reconciliation of GAAP to non-GAAP results may be found in our earnings release and stakeholder letter, which were furnished with our Form 8-K filed after the market closed today with the SEC and may also be found on our Investor Relations website at ir.phreesia.com. I will now turn the call over to our CEO, Chaim Indig.</td><td>ë˜í•œ íˆ¬ììë“¤ì—ê²Œ ì¶”ê°€ ì •ë³´ë¥¼ ì œê³µí•˜ê¸° ìœ„í•´ ì¡°ì • EBITDA ë° ì‰ì—¬í˜„ê¸ˆíë¦„ê³¼ ê°™ì€ ì¼ë°˜ì ìœ¼ë¡œ ì¸ì •ëœ íšŒê³„ì›ì¹™ì— ë”°ë¥´ì§€ ì•ŠëŠ” íŠ¹ì • ì¬ë¬´ ì§€í‘œë¥¼ ì–¸ê¸‰í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤. ì´ëŸ¬í•œ ë¹„-GAAP ì§€í‘œëŠ” GAAP ê²°ê³¼ë¥¼ ëŒ€ì²´í•˜ê±°ë‚˜ ë…ë¦½ì ìœ¼ë¡œ ì‚¬ìš©ë˜ëŠ” ê²ƒì´ ì•„ë‹ˆë¼ ì¶”ê°€ì ìœ¼ë¡œ ê³ ë ¤ë˜ì–´ì•¼ í•©ë‹ˆë‹¤. GAAPì—ì„œ ë¹„-GAAPë¡œì˜ ì¡°ì • ë‚´ì—­ì€ ì˜¤ëŠ˜ ì¥ ë§ˆê° í›„ SECì— ì œì¶œëœ Form 8-Kì™€ í•¨ê»˜ ì œê³µëœ ì‹¤ì  ë°œí‘œ ìë£Œ ë° ì£¼ì£¼ ì„œí•œì—ì„œ í™•ì¸í•˜ì‹¤ ìˆ˜ ìˆìœ¼ë©°, ë‹¹ì‚¬ íˆ¬ìì ê´€ê³„ ì›¹ì‚¬ì´íŠ¸ ir.phreesia.comì—ì„œë„ í™•ì¸í•˜ì‹¤ ìˆ˜ ìˆìŠµë‹ˆë‹¤. ì´ì œ CEOì¸ Chaim Indigì—ê²Œ ë°œì–¸ê¶Œì„ ë„˜ê¸°ê² ìŠµë‹ˆë‹¤.</td></tr>
<tr><td>Chaim Indig<br>Co-Founder, CEO & Director<br><br>Thank you, Balaji, and good evening, everyone. Thank you for joining our third quarter fiscal 2026 earnings call. I'm very proud and thankful of our team, the work they do for our clients and their contribution to another solid quarter of growth and profitability. Balaji will review some of the highlights of our results and update our outlook. Before I hand it off to Balaji, I'd like to frame our view of Phreesia's next 3 years for all of you. Today, we have a large network of health care providers, who rely on Phreesia's products and services.</td><td>ì°¨ì„ ì¸ë”•(Chaim Indig)<br>ê³µë™ ì°½ë¦½ì, CEO ê²¸ ì´ì‚¬<br><br>ë°œë¼ì§€, ê°ì‚¬í•©ë‹ˆë‹¤. ê·¸ë¦¬ê³  ì—¬ëŸ¬ë¶„ ëª¨ë‘ ì•ˆë…•í•˜ì‹­ë‹ˆê¹Œ. 2026 íšŒê³„ì—°ë„ 3ë¶„ê¸° ì‹¤ì  ë°œí‘œ ì»¨í¼ëŸ°ìŠ¤ ì½œì— ì°¸ì„í•´ ì£¼ì…”ì„œ ê°ì‚¬í•©ë‹ˆë‹¤. ì €ëŠ” ìš°ë¦¬ íŒ€ê³¼ ê·¸ë“¤ì´ ê³ ê°ì„ ìœ„í•´ í•˜ëŠ” ì¼, ê·¸ë¦¬ê³  ë˜ í•œ ë¶„ê¸°ì˜ ê²¬ê³ í•œ ì„±ì¥ê³¼ ìˆ˜ìµì„±ì— ëŒ€í•œ ê·¸ë“¤ì˜ ê¸°ì—¬ì— ëŒ€í•´ ë§¤ìš° ìë‘ìŠ¤ëŸ½ê³  ê°ì‚¬í•˜ê²Œ ìƒê°í•©ë‹ˆë‹¤. ë°œë¼ì§€ê°€ ìš°ë¦¬ ì‹¤ì ì˜ ì£¼ìš” ë‚´ìš©ì„ ê²€í† í•˜ê³  ì „ë§ì„ ì—…ë°ì´íŠ¸í•  ê²ƒì…ë‹ˆë‹¤. ë°œë¼ì§€ì—ê²Œ ë„˜ê¸°ê¸° ì „ì—, ì—¬ëŸ¬ë¶„ ëª¨ë‘ë¥¼ ìœ„í•´ í”„ë¦¬ì§€ì•„(Phreesia)ì˜ í–¥í›„ 3ë…„ì— ëŒ€í•œ ìš°ë¦¬ì˜ ê´€ì ì„ ë§ì”€ë“œë¦¬ê³ ì í•©ë‹ˆë‹¤. ì˜¤ëŠ˜ë‚  ìš°ë¦¬ëŠ” í”„ë¦¬ì§€ì•„ì˜ ì œí’ˆê³¼ ì„œë¹„ìŠ¤ì— ì˜ì¡´í•˜ëŠ” ëŒ€ê·œëª¨ ì˜ë£Œ ì„œë¹„ìŠ¤ ì œê³µì ë„¤íŠ¸ì›Œí¬ë¥¼ ë³´ìœ í•˜ê³  ìˆìŠµë‹ˆë‹¤.</td></tr>
<tr><td>We also have new emerging products that extend our reach in ways that is consistent with our mission to make care easier every day. We believe these emerging products will enable us to sustain growth and enhance stakeholder value. I'd like to highlight 2 of the product areas we are excited about. First, provider financing. It's no secret that patient financial responsibility has been rising in this country, and we expect this trend to continue. People can't afford to pay their bills all at once. Our platform has enabled us to track this trend for years. For health care providers, this means more patient balances go unpaid, payment cycles get longer and providers carry more financial risk.</td><td>ë˜í•œ ìš°ë¦¬ëŠ” ë§¤ì¼ ì˜ë£Œ ì„œë¹„ìŠ¤ë¥¼ ë” ì‰½ê²Œ ë§Œë“ ë‹¤ëŠ” ìš°ë¦¬ì˜ ì‚¬ëª…ê³¼ ì¼ì¹˜í•˜ëŠ” ë°©ì‹ìœ¼ë¡œ ì‚¬ì—… ì˜ì—­ì„ í™•ì¥í•˜ëŠ” ìƒˆë¡œìš´ ì‹ ì œí’ˆë“¤ì„ ë³´ìœ í•˜ê³  ìˆìŠµë‹ˆë‹¤. ìš°ë¦¬ëŠ” ì´ëŸ¬í•œ ì‹ ì œí’ˆë“¤ì´ ì§€ì†ì ì¸ ì„±ì¥ì„ ê°€ëŠ¥í•˜ê²Œ í•˜ê³  ì´í•´ê´€ê³„ì ê°€ì¹˜ë¥¼ í–¥ìƒì‹œí‚¬ ê²ƒìœ¼ë¡œ ë¯¿ìŠµë‹ˆë‹¤. ìš°ë¦¬ê°€ ê¸°ëŒ€í•˜ê³  ìˆëŠ” ë‘ ê°€ì§€ ì œí’ˆ ì˜ì—­ì„ ê°•ì¡°í•˜ê³  ì‹¶ìŠµë‹ˆë‹¤. ì²«ì§¸, ì˜ë£Œê¸°ê´€ ê¸ˆìœµì…ë‹ˆë‹¤. ì´ ë‚˜ë¼ì—ì„œ í™˜ìì˜ ì¬ì •ì  ë¶€ë‹´ì´ ì¦ê°€í•˜ê³  ìˆë‹¤ëŠ” ê²ƒì€ ë¹„ë°€ì´ ì•„ë‹ˆë©°, ìš°ë¦¬ëŠ” ì´ëŸ¬í•œ ì¶”ì„¸ê°€ ê³„ì†ë  ê²ƒìœ¼ë¡œ ì˜ˆìƒí•©ë‹ˆë‹¤. ì‚¬ëŒë“¤ì€ ì²­êµ¬ì„œë¥¼ í•œ ë²ˆì— ì§€ë¶ˆí•  ì—¬ë ¥ì´ ì—†ìŠµë‹ˆë‹¤. ìš°ë¦¬ í”Œë«í¼ì€ ìˆ˜ë…„ê°„ ì´ëŸ¬í•œ ì¶”ì„¸ë¥¼ ì¶”ì í•  ìˆ˜ ìˆê²Œ í•´ì£¼ì—ˆìŠµë‹ˆë‹¤. ì˜ë£Œ ì„œë¹„ìŠ¤ ì œê³µìë“¤ì—ê²Œ ì´ëŠ” ë” ë§ì€ í™˜ì ë¯¸ìˆ˜ê¸ˆì´ ë¯¸ì§€ê¸‰ ìƒíƒœë¡œ ë‚¨ê³ , ìˆ˜ê¸ˆ ì£¼ê¸°ê°€ ê¸¸ì–´ì§€ë©°, ì˜ë£Œê¸°ê´€ë“¤ì´ ë” ë§ì€ ì¬ì •ì  ìœ„í—˜ì„ ë– ì•ˆê²Œ ëœë‹¤ëŠ” ê²ƒì„ ì˜ë¯¸í•©ë‹ˆë‹¤.</td></tr>
<tr><td>Hospitals and health systems have seen the number of days cash on hand declined by 28% since 2022. As a result, providers need tools to convert patient receivables into predictable cash flow. Patient balances often take years to resolve, which creates working capital pressure for providers. Our financing solutions improved days cash on hand and decrease days outstanding. Financing or payment plan programs can significantly improve the patient experience and affordability and decreases the need to use credit cards or a home equity line.</td><td>ë³‘ì›ê³¼ ì˜ë£Œ ì‹œìŠ¤í…œì˜ í˜„ê¸ˆë³´ìœ ì¼ìˆ˜(days cash on hand)ëŠ” 2022ë…„ ì´í›„ 28% ê°ì†Œí–ˆìŠµë‹ˆë‹¤. ê·¸ ê²°ê³¼, ì˜ë£Œ ì„œë¹„ìŠ¤ ì œê³µìë“¤ì€ í™˜ì ë¯¸ìˆ˜ê¸ˆì„ ì˜ˆì¸¡ ê°€ëŠ¥í•œ í˜„ê¸ˆíë¦„ìœ¼ë¡œ ì „í™˜í•  ìˆ˜ ìˆëŠ” ë„êµ¬ê°€ í•„ìš”í•©ë‹ˆë‹¤. í™˜ì ë¯¸ê²°ì œ ì”ì•¡ì€ í•´ê²°í•˜ëŠ” ë° ì¢…ì¢… ìˆ˜ë…„ì´ ê±¸ë¦¬ë©°, ì´ëŠ” ì˜ë£Œ ì„œë¹„ìŠ¤ ì œê³µìë“¤ì—ê²Œ ìš´ì „ìë³¸ ì••ë°•ì„ ì´ˆë˜í•©ë‹ˆë‹¤. ë‹¹ì‚¬ì˜ ê¸ˆìœµ ì†”ë£¨ì…˜ì€ í˜„ê¸ˆë³´ìœ ì¼ìˆ˜ë¥¼ ê°œì„ í•˜ê³  ë¯¸ìˆ˜ê¸ˆ íšŒìˆ˜ê¸°ê°„(days outstanding)ì„ ë‹¨ì¶•ì‹œí‚µë‹ˆë‹¤. ê¸ˆìœµ ë˜ëŠ” ë¶„í• ë‚©ë¶€ í”„ë¡œê·¸ë¨ì€ í™˜ì ê²½í—˜ê³¼ ì§€ë¶ˆ ê°€ëŠ¥ì„±ì„ í¬ê²Œ í–¥ìƒì‹œí‚¬ ìˆ˜ ìˆìœ¼ë©°, ì‹ ìš©ì¹´ë“œë‚˜ ì£¼íƒë‹´ë³´ëŒ€ì¶œì„ ì‚¬ìš©í•  í•„ìš”ì„±ì„ ì¤„ì—¬ì¤ë‹ˆë‹¤.</td></tr>
<tr><td>Our expansion into the provider financing market through the acquisition of AccessOne helps us solve this large and growing problem with a market-leading solution. We believe we have a new growth lever to complement our existing solutions for providers and are excited about this opportunity. The second emerging market for us is Health Care Provider or HCP marketing. HCP engagement is a natural extension of the offering that works so well to engage patients. We help providers and life sciences partners engage patients just before key visits, where important health decisions are made, supporting behavioral change in positive measurable outcomes.</td><td>ë‹¹ì‚¬ê°€ AccessOne ì¸ìˆ˜ë¥¼ í†µí•´ ì˜ë£Œê¸°ê´€ ê¸ˆìœµ ì‹œì¥ìœ¼ë¡œ í™•ì¥í•œ ê²ƒì€ ì´ëŸ¬í•œ í¬ê³  ì¦ê°€í•˜ëŠ” ë¬¸ì œë¥¼ ì‹œì¥ ì„ ë„ì ì¸ ì†”ë£¨ì…˜ìœ¼ë¡œ í•´ê²°í•˜ëŠ” ë° ë„ì›€ì´ ë©ë‹ˆë‹¤. ìš°ë¦¬ëŠ” ì˜ë£Œê¸°ê´€ì„ ìœ„í•œ ê¸°ì¡´ ì†”ë£¨ì…˜ì„ ë³´ì™„í•  ìƒˆë¡œìš´ ì„±ì¥ ë™ë ¥ì„ í™•ë³´í–ˆë‹¤ê³  ë¯¿ìœ¼ë©°, ì´ ê¸°íšŒì— ëŒ€í•´ ê¸°ëŒ€í•˜ê³  ìˆìŠµë‹ˆë‹¤. ìš°ë¦¬ì˜ ë‘ ë²ˆì§¸ ì‹ í¥ ì‹œì¥ì€ ì˜ë£Œ ì „ë¬¸ê°€(HCP) ë§ˆì¼€íŒ…ì…ë‹ˆë‹¤. HCP ì¸ê²Œì´ì§€ë¨¼íŠ¸ëŠ” í™˜ì ì°¸ì—¬ì— íš¨ê³¼ì ìœ¼ë¡œ ì‘ìš©í•˜ëŠ” ì„œë¹„ìŠ¤ì˜ ìì—°ìŠ¤ëŸ¬ìš´ í™•ì¥ì…ë‹ˆë‹¤. ìš°ë¦¬ëŠ” ì˜ë£Œê¸°ê´€ê³¼ ìƒëª…ê³¼í•™ íŒŒíŠ¸ë„ˆë“¤ì´ ì¤‘ìš”í•œ ê±´ê°• ê²°ì •ì´ ì´ë£¨ì–´ì§€ëŠ” ì£¼ìš” ì§„ë£Œ ì§ì „ì— í™˜ìë“¤ê³¼ ì†Œí†µí•  ìˆ˜ ìˆë„ë¡ ì§€ì›í•˜ë©°, ì´ëŠ” í–‰ë™ ë³€í™”ì™€ ê¸ì •ì ì´ê³  ì¸¡ì • ê°€ëŠ¥í•œ ê²°ê³¼ë¥¼ ë’·ë°›ì¹¨í•©ë‹ˆë‹¤.</td></tr>
<tr><td>Now we're extending that same proven playbook to engage health care providers in addition to patients. This positions Phreesia to participate in a multibillion dollar HCP digital marketing opportunity, while leveraging the trusted relationships and infrastructure we've already built. Our approach differentiates Phreesia by closing the loop between patient and provider engagement. Because we're embedded in clinical workflows, we help coordinate consumer and HCP messaging, ensuring that both are prepared for upcoming appointments, reaching physicians with relevant evidence based information before they see the right patient, not weeks or months later.</td><td>ì´ì œ ìš°ë¦¬ëŠ” í™˜ì ì™¸ì— ì˜ë£Œ ì„œë¹„ìŠ¤ ì œê³µì(HCP)ë¥¼ ì°¸ì—¬ì‹œí‚¤ê¸° ìœ„í•´ ë™ì¼í•˜ê²Œ ê²€ì¦ëœ í”Œë ˆì´ë¶ì„ í™•ì¥í•˜ê³  ìˆìŠµë‹ˆë‹¤. ì´ëŠ” Phreesiaê°€ ì´ë¯¸ êµ¬ì¶•í•œ ì‹ ë¢°ë°›ëŠ” ê´€ê³„ì™€ ì¸í”„ë¼ë¥¼ í™œìš©í•˜ë©´ì„œ ìˆ˜ì‹­ì–µ ë‹¬ëŸ¬ ê·œëª¨ì˜ HCP ë””ì§€í„¸ ë§ˆì¼€íŒ… ê¸°íšŒì— ì°¸ì—¬í•  ìˆ˜ ìˆëŠ” ìœ„ì¹˜ë¥¼ í™•ë³´í•˜ê²Œ í•©ë‹ˆë‹¤. ìš°ë¦¬ì˜ ì ‘ê·¼ ë°©ì‹ì€ í™˜ìì™€ ì˜ë£Œì§„ ì°¸ì—¬ ê°„ì˜ ë£¨í”„ë¥¼ ì™„ì„±í•¨ìœ¼ë¡œì¨ Phreesiaë¥¼ ì°¨ë³„í™”í•©ë‹ˆë‹¤. ìš°ë¦¬ëŠ” ì„ìƒ ì›Œí¬í”Œë¡œìš°ì— ë‚´ì¬ë˜ì–´ ìˆê¸° ë•Œë¬¸ì—, ì†Œë¹„ìì™€ HCP ë©”ì‹œì§•ì„ ì¡°ìœ¨í•˜ì—¬ ì–‘ì¸¡ ëª¨ë‘ê°€ ì˜ˆì •ëœ ì§„ë£Œ ì˜ˆì•½ì— ëŒ€ë¹„í•  ìˆ˜ ìˆë„ë¡ ì§€ì›í•˜ë©°, ëª‡ ì£¼ë‚˜ ëª‡ ë‹¬ í›„ê°€ ì•„ë‹Œ ì ì ˆí•œ í™˜ìë¥¼ ì§„ë£Œí•˜ê¸° ì „ì— ê´€ë ¨ ê·¼ê±° ê¸°ë°˜ ì •ë³´ë¥¼ ì˜ì‚¬ì—ê²Œ ì „ë‹¬í•©ë‹ˆë‹¤.</td></tr>
<tr><td>Our ability to align both sides of the care conversation is something we believe no one else in the market can do as comprehensively as Phreesia. Our acquisitions are central to our ability to understand, reach and engage health care providers. MediFind brings deep insights into appointments with active providers in specialty care patterns, helping us identify when specific clinicians need information about specific conditions or treatments based on their upcoming appointments. ConnectOnCall. Now PhreesiaOnCall, along with our voice AI capabilities, allow us to introduce high-value enrollments directly into the provider workflow.</td><td>ì˜ë£Œ ëŒ€í™”ì˜ ì–‘ì¸¡ì„ ì—°ê²°í•˜ëŠ” ìš°ë¦¬ì˜ ì—­ëŸ‰ì€ ì‹œì¥ì—ì„œ Phreesiaë§Œí¼ í¬ê´„ì ìœ¼ë¡œ ìˆ˜í–‰í•  ìˆ˜ ìˆëŠ” ê¸°ì—…ì´ ì—†ë‹¤ê³  ë¯¿ìŠµë‹ˆë‹¤. ìš°ë¦¬ì˜ ì¸ìˆ˜ ê¸°ì—…ë“¤ì€ ì˜ë£Œ ì„œë¹„ìŠ¤ ì œê³µìë¥¼ ì´í•´í•˜ê³ , ë„ë‹¬í•˜ë©°, ì°¸ì—¬ì‹œí‚¤ëŠ” ëŠ¥ë ¥ì˜ í•µì‹¬ì…ë‹ˆë‹¤. MediFindëŠ” ì „ë¬¸ ì§„ë£Œ íŒ¨í„´ì—ì„œ í™œë™ ì¤‘ì¸ ì˜ë£Œì§„ê³¼ì˜ ì˜ˆì•½ì— ëŒ€í•œ ì‹¬ì¸µì ì¸ ì¸ì‚¬ì´íŠ¸ë¥¼ ì œê³µí•˜ì—¬, ì˜ˆì •ëœ ì˜ˆì•½ì„ ê¸°ë°˜ìœ¼ë¡œ íŠ¹ì • ì„ìƒì˜ê°€ íŠ¹ì • ì§ˆí™˜ì´ë‚˜ ì¹˜ë£Œë²•ì— ëŒ€í•œ ì •ë³´ê°€ í•„ìš”í•œ ì‹œì ì„ íŒŒì•…í•  ìˆ˜ ìˆë„ë¡ ë•ìŠµë‹ˆë‹¤. ConnectOnCall, í˜„ì¬ PhreesiaOnCallë¡œ ë¶ˆë¦¬ëŠ” ì´ ì„œë¹„ìŠ¤ëŠ” ìŒì„± AI ê¸°ëŠ¥ê³¼ í•¨ê»˜ ê³ ë¶€ê°€ê°€ì¹˜ ë“±ë¡ì„ ì˜ë£Œ ì„œë¹„ìŠ¤ ì œê³µìì˜ ì›Œí¬í”Œë¡œìš°ì— ì§ì ‘ ë„ì…í•  ìˆ˜ ìˆê²Œ í•´ì¤ë‹ˆë‹¤.</td></tr>
<tr><td>Together, these assets create a premium endemic offering and help us reach a broad set of providers in the natural flow of care, not just when they're off the clock. This new initiative plays into our strength. We have 2 decades of experience working with thousands of provider organizations in the top 10 pharma companies, earning a reputation for performance, compliance and truly consultative partnerships. By making HCP activation available within that same trusted ecosystem and centered on real care encounters we believe it will deepen our relationship with both providers and life sciences clients while adding a durable, differentiated revenue stream to Phreesia's growth story.</td><td>ì´ëŸ¬í•œ ìì‚°ë“¤ì„ ê²°í•©í•˜ì—¬ í”„ë¦¬ë¯¸ì—„ ì „ë¬¸ ì˜ë£Œ ì†”ë£¨ì…˜ì„ ì œê³µí•˜ê³ , ì˜ë£Œì§„ì´ ê·¼ë¬´ ì™¸ ì‹œê°„ì´ ì•„ë‹Œ ì§„ë£Œ ê³¼ì •ì—ì„œ ìì—°ìŠ¤ëŸ½ê²Œ ê´‘ë²”ìœ„í•œ ì˜ë£Œ ì œê³µìë“¤ì—ê²Œ ë„ë‹¬í•  ìˆ˜ ìˆê²Œ í•©ë‹ˆë‹¤. ì´ ìƒˆë¡œìš´ ì´ë‹ˆì…”í‹°ë¸ŒëŠ” ìš°ë¦¬ì˜ ê°•ì ì„ í™œìš©í•©ë‹ˆë‹¤. ìš°ë¦¬ëŠ” 20ë…„ê°„ ìˆ˜ì²œ ê°œì˜ ì˜ë£Œ ê¸°ê´€ê³¼ ìƒìœ„ 10ëŒ€ ì œì•½íšŒì‚¬ë“¤ê³¼ í˜‘ë ¥í•˜ë©° ì„±ê³¼, ê·œì • ì¤€ìˆ˜, ê·¸ë¦¬ê³  ì§„ì •í•œ ì»¨ì„¤íŒ… íŒŒíŠ¸ë„ˆì‹­ìœ¼ë¡œ ëª…ì„±ì„ ìŒ“ì•„ì™”ìŠµë‹ˆë‹¤. ì‹ ë¢°ë°›ëŠ” ë™ì¼í•œ ìƒíƒœê³„ ë‚´ì—ì„œ ì‹¤ì œ ì§„ë£Œ ìƒí™©ì„ ì¤‘ì‹¬ìœ¼ë¡œ HCP(ì˜ë£Œ ì „ë¬¸ê°€) í™œì„±í™”ë¥¼ ì œê³µí•¨ìœ¼ë¡œì¨, ì˜ë£Œ ì œê³µì ë° ìƒëª…ê³¼í•™ ê³ ê°ë“¤ê³¼ì˜ ê´€ê³„ë¥¼ ë”ìš± ê¹Šê²Œ ë§Œë“¤ê³  Phreesiaì˜ ì„±ì¥ ìŠ¤í† ë¦¬ì— ì§€ì† ê°€ëŠ¥í•˜ê³  ì°¨ë³„í™”ëœ ìˆ˜ìµì›ì„ ì¶”ê°€í•  ê²ƒìœ¼ë¡œ ë¯¿ìŠµë‹ˆë‹¤.</td></tr>
<tr><td>We look forward to updating you on these 2 important initiatives when we speak on 2026. I'll now turn it over to Balaji to walk through the Q3 results, our updated outlook for fiscal 2026 and an initial view into fiscal 2027. Balaji Gandhi<br>Chief Financial Officer<br><br>Thank you, Chaim. Let me start with a quick review of our fiscal third quarter. Total revenue was $120.3 million a 13% increase year-over-year. Adjusted EBITDA was $29.1 million, an increase of $19 million year-over-year and $7 million quarter-over-quarter.</td><td>ì´ ë‘ ê°€ì§€ ì¤‘ìš”í•œ ì´ë‹ˆì…”í‹°ë¸Œì— ëŒ€í•´ì„œëŠ” 2026ë…„ì— ë‹¤ì‹œ ë§ì”€ë“œë¦¬ê² ìŠµë‹ˆë‹¤. ì´ì œ Balajiì—ê²Œ ë§ˆì´í¬ë¥¼ ë„˜ê²¨ 3ë¶„ê¸° ì‹¤ì , 2026 íšŒê³„ì—°ë„ ì—…ë°ì´íŠ¸ëœ ì „ë§, ê·¸ë¦¬ê³  2027 íšŒê³„ì—°ë„ì— ëŒ€í•œ ì´ˆê¸° ì „ë§ì„ ì„¤ëª…í•˜ë„ë¡ í•˜ê² ìŠµë‹ˆë‹¤.<br><br>Balaji Gandhi<br>ìµœê³ ì¬ë¬´ì±…ì„ì(CFO)<br><br>ê°ì‚¬í•©ë‹ˆë‹¤, Chaim. ë¨¼ì € 3ë¶„ê¸° ì‹¤ì ì„ ê°„ë‹¨íˆ ê²€í† í•˜ê² ìŠµë‹ˆë‹¤. ì´ ë§¤ì¶œì€ 1ì–µ 2,030ë§Œ ë‹¬ëŸ¬ë¡œ ì „ë…„ ë™ê¸° ëŒ€ë¹„ 13% ì¦ê°€í–ˆìŠµë‹ˆë‹¤. ì¡°ì • EBITDAëŠ” 2,910ë§Œ ë‹¬ëŸ¬ë¡œ ì „ë…„ ë™ê¸° ëŒ€ë¹„ 1,900ë§Œ ë‹¬ëŸ¬, ì „ë¶„ê¸° ëŒ€ë¹„ 700ë§Œ ë‹¬ëŸ¬ ì¦ê°€í–ˆìŠµë‹ˆë‹¤.</td></tr>
<tr><td>We achieved another major milestone this quarter with our adjusted EBITDA margin reaching an all-time high of 24%, representing an improvement of 5 percentage points quarter-over-quarter and 15 percentage points year-over-year. For fiscal third quarter G&A expense line included a onetime G&A tax benefit, which increased adjusted EBITDA by $900,000. Third quarter Average Healthcare Services Clients or AHSCs came in at 4,520, an increase of 53 from the prior quarter. This performance was in line with our expectations and we believe we are on track to reach 4,500 Average Healthcare Services Clients or AHSCs for the full fiscal year.</td><td>ì´ë²ˆ ë¶„ê¸°ì— ì¡°ì • EBITDA ë§ˆì§„ì´ ì‚¬ìƒ ìµœê³ ì¹˜ì¸ 24%ë¥¼ ë‹¬ì„±í•˜ë©° ë˜ ë‹¤ë¥¸ ì¤‘ìš”í•œ ì´ì •í‘œë¥¼ ì„¸ì› ìŠµë‹ˆë‹¤. ì´ëŠ” ì „ë¶„ê¸° ëŒ€ë¹„ 5%í¬ì¸íŠ¸, ì „ë…„ ë™ê¸° ëŒ€ë¹„ 15%í¬ì¸íŠ¸ ê°œì„ ëœ ìˆ˜ì¹˜ì…ë‹ˆë‹¤. 3ë¶„ê¸° ì¼ë°˜ê´€ë¦¬ë¹„ í•­ëª©ì—ëŠ” ì¼íšŒì„± ì„¸ê¸ˆ í˜œíƒì´ í¬í•¨ë˜ì–´ ìˆìœ¼ë©°, ì´ë¡œ ì¸í•´ ì¡°ì • EBITDAê°€ 90ë§Œ ë‹¬ëŸ¬ ì¦ê°€í–ˆìŠµë‹ˆë‹¤. 3ë¶„ê¸° í‰ê·  í—¬ìŠ¤ì¼€ì–´ ì„œë¹„ìŠ¤ ê³ ê°ì‚¬(AHSCs)ëŠ” 4,520ê°œë¡œ ì „ë¶„ê¸° ëŒ€ë¹„ 53ê°œ ì¦ê°€í–ˆìŠµë‹ˆë‹¤. ì´ëŸ¬í•œ ì‹¤ì ì€ ë‹¹ì‚¬ì˜ ì˜ˆìƒê³¼ ì¼ì¹˜í•˜ë©°, ì „ì²´ íšŒê³„ì—°ë„ ê¸°ì¤€ìœ¼ë¡œ í‰ê·  í—¬ìŠ¤ì¼€ì–´ ì„œë¹„ìŠ¤ ê³ ê°ì‚¬(AHSCs) 4,500ê°œ ë‹¬ì„± ëª©í‘œë¥¼ ìˆœì¡°ë¡­ê²Œ ì§„í–‰í•˜ê³  ìˆë‹¤ê³  íŒë‹¨ë©ë‹ˆë‹¤.</td></tr>
<tr><td>Meeting this target implies adding approximately 70 clients in the fiscal fourth quarter, excluding the impact from the AccessOne acquisition. Total revenue per AHSC was $26,622, up 6% year-over-year. The steady year-over-year increase in total revenue per AHSC is consistent with our expectations and a key element of our growth strategy that we have been discussing for several quarters. We are pleased with the continued progress of this metric as it has returned to the levels as seen in the third quarter of fiscal 2022 and reflects our focus on improving returns on investment and attach rates of our collective offerings across our 3 revenue streams.</td><td>ì´ ëª©í‘œë¥¼ ë‹¬ì„±í•˜ê¸° ìœ„í•´ì„œëŠ” AccessOne ì¸ìˆ˜ ì˜í–¥ì„ ì œì™¸í•˜ê³  4ë¶„ê¸°ì— ì•½ 70ê°œì˜ ê³ ê°ì‚¬ë¥¼ ì¶”ê°€í•´ì•¼ í•©ë‹ˆë‹¤. AHSCë‹¹ ì´ ë§¤ì¶œì€ 26,622ë‹¬ëŸ¬ë¡œ ì „ë…„ ë™ê¸° ëŒ€ë¹„ 6% ì¦ê°€í–ˆìŠµë‹ˆë‹¤. AHSCë‹¹ ì´ ë§¤ì¶œì˜ ê¾¸ì¤€í•œ ì „ë…„ ëŒ€ë¹„ ì¦ê°€ëŠ” ìš°ë¦¬ì˜ ì˜ˆìƒê³¼ ì¼ì¹˜í•˜ë©°, ì§€ë‚œ ëª‡ ë¶„ê¸° ë™ì•ˆ ë…¼ì˜í•´ ì˜¨ ì„±ì¥ ì „ëµì˜ í•µì‹¬ ìš”ì†Œì…ë‹ˆë‹¤. ì´ ì§€í‘œê°€ 2022 íšŒê³„ì—°ë„ 3ë¶„ê¸° ìˆ˜ì¤€ìœ¼ë¡œ íšŒë³µë˜ì—ˆë‹¤ëŠ” ì ì—ì„œ ì§€ì†ì ì¸ ê°œì„ ì— ë§Œì¡±í•˜ê³  ìˆìœ¼ë©°, ì´ëŠ” 3ê°œ ë§¤ì¶œì›(revenue stream) ì „ë°˜ì— ê±¸ì¹œ ìš°ë¦¬ì˜ í†µí•© ì†”ë£¨ì…˜ì— ëŒ€í•œ íˆ¬ì ìˆ˜ìµë¥ ê³¼ ê²°í•©ë¥ (attach rate) ê°œì„ ì— ì§‘ì¤‘í•˜ê³  ìˆìŒì„ ë°˜ì˜í•©ë‹ˆë‹¤.</td></tr>
<tr><td>Net income remained positive at $4.3 million this quarter, representing our second consecutive quarter of delivering positive net income. Our fiscal third quarter results reflect the continued momentum in both our revenue growth and operating leverage. I'm incredibly proud of the team's disciplined execution and focus, which again enabled us to deliver strong financial performance, while staying true to our mission and values. I also want to acknowledge all the Phreesians played a role in successfully closing the AccessOne acquisition, and I joined Chaim in welcoming our new colleagues from AccessOne. Now turning to the balance sheet and cash flow.</td><td>ë‹¹ê¸°ìˆœì´ìµì€ 430ë§Œ ë‹¬ëŸ¬ í‘ìë¥¼ ìœ ì§€í•˜ë©°, 2ë¶„ê¸° ì—°ì† í‘ì ë‹¬ì„±ì„ ê¸°ë¡í–ˆìŠµë‹ˆë‹¤. 3ë¶„ê¸° ì‹¤ì ì€ ë§¤ì¶œ ì„±ì¥ê³¼ ì˜ì—… ë ˆë²„ë¦¬ì§€ ëª¨ë‘ì—ì„œ ì§€ì†ì ì¸ ëª¨ë©˜í…€ì„ ë°˜ì˜í•˜ê³  ìˆìŠµë‹ˆë‹¤. ì €ëŠ” ìš°ë¦¬ì˜ ì‚¬ëª…ê³¼ ê°€ì¹˜ì— ì¶©ì‹¤í•˜ë©´ì„œë„ ë‹¤ì‹œ í•œë²ˆ ê°•ë ¥í•œ ì¬ë¬´ ì„±ê³¼ë¥¼ ë‹¬ì„±í•  ìˆ˜ ìˆê²Œ í•œ íŒ€ì˜ ê·œìœ¨ ìˆëŠ” ì‹¤í–‰ë ¥ê³¼ ì§‘ì¤‘ë ¥ì´ ë§¤ìš° ìë‘ìŠ¤ëŸ½ìŠµë‹ˆë‹¤. ë˜í•œ AccessOne ì¸ìˆ˜ë¥¼ ì„±ê³µì ìœ¼ë¡œ ë§ˆë¬´ë¦¬í•˜ëŠ” ë° ê¸°ì—¬í•œ ëª¨ë“  Phreesia ì„ì§ì›ë“¤ì—ê²Œ ê°ì‚¬ì˜ ë§ì”€ì„ ì „í•˜ë©°, Chaimê³¼ í•¨ê»˜ AccessOneì˜ ìƒˆë¡œìš´ ë™ë£Œë“¤ì„ í™˜ì˜í•©ë‹ˆë‹¤. ì´ì œ ëŒ€ì°¨ëŒ€ì¡°í‘œì™€ í˜„ê¸ˆíë¦„ìœ¼ë¡œ ë„˜ì–´ê°€ê² ìŠµë‹ˆë‹¤.</td></tr>
<tr><td>We ended the quarter with $106.4 million in cash and cash equivalents. This compares to $98.3 million in the prior quarter. Operating cash flow was $15.5 million, up $9.7 million year-over-year. Free cash flow was $8.8 million, up $7.2 million year-over-year. We have now achieved positive operating cash flow and free cash flow for 5 consecutive quarters. We expect the magnitude of improvement on a quarter-to-quarter basis to vary based on specific timing of invoicing and payments, which you can see in working capital, along with CapEx. A footnote on the balance sheet.</td><td>ë‹¹ì‚¬ëŠ” ë¶„ê¸° ë§ í˜„ì¬ í˜„ê¸ˆ ë° í˜„ê¸ˆì„± ìì‚°ì´ 1ì–µ 640ë§Œ ë‹¬ëŸ¬ë¥¼ ê¸°ë¡í–ˆìŠµë‹ˆë‹¤. ì´ëŠ” ì „ ë¶„ê¸°ì˜ 9,830ë§Œ ë‹¬ëŸ¬ì™€ ë¹„êµë˜ëŠ” ìˆ˜ì¹˜ì…ë‹ˆë‹¤. ì˜ì—…í˜„ê¸ˆíë¦„ì€ 1,550ë§Œ ë‹¬ëŸ¬ë¡œ ì „ë…„ ë™ê¸° ëŒ€ë¹„ 970ë§Œ ë‹¬ëŸ¬ ì¦ê°€í–ˆìŠµë‹ˆë‹¤. ì‰ì—¬í˜„ê¸ˆíë¦„ì€ 880ë§Œ ë‹¬ëŸ¬ë¡œ ì „ë…„ ë™ê¸° ëŒ€ë¹„ 720ë§Œ ë‹¬ëŸ¬ ì¦ê°€í–ˆìŠµë‹ˆë‹¤. ë‹¹ì‚¬ëŠ” ì´ì œ 5ê°œ ë¶„ê¸° ì—°ì†ìœ¼ë¡œ ì˜ì—…í˜„ê¸ˆíë¦„ê³¼ ì‰ì—¬í˜„ê¸ˆíë¦„ í‘ìë¥¼ ë‹¬ì„±í–ˆìŠµë‹ˆë‹¤. ë¶„ê¸°ë³„ ê°œì„  í­ì€ ì²­êµ¬ ë° ì§€ê¸‰ì˜ êµ¬ì²´ì ì¸ ì‹œê¸°ì— ë”°ë¼ ë‹¬ë¼ì§ˆ ê²ƒìœ¼ë¡œ ì˜ˆìƒë˜ë©°, ì´ëŠ” ìš´ì „ìë³¸ê³¼ ìë³¸ì  ì§€ì¶œì—ì„œ í™•ì¸í•˜ì‹¤ ìˆ˜ ìˆìŠµë‹ˆë‹¤. ëŒ€ì°¨ëŒ€ì¡°í‘œì— ëŒ€í•œ ì£¼ì„ ì‚¬í•­ì…ë‹ˆë‹¤.</td></tr>
<tr><td>As you look ahead to the fourth quarter, the AccessOne purchase price was funded with approximately $53 million of cash and a $110 million secured bridge loan entered into on the closing date of the acquisition. You can find more information about our bridge loan in our 8-K filing from November 12. We expect to refinance or replace the bridge loan with a long-term credit facility. Before moving into our updated financial outlook for fiscal 2026 and new outlook for fiscal 2027, let me provide a few highlights on AccessOne. AccessOne provides financing solutions that help health care providers reduce patient accounts receivable and accelerate cash flow.</td><td>4ë¶„ê¸°ë¥¼ ì „ë§í•˜ë©´, AccessOne ì¸ìˆ˜ëŒ€ê¸ˆì€ ì•½ 5,300ë§Œ ë‹¬ëŸ¬ì˜ í˜„ê¸ˆê³¼ ì¸ìˆ˜ ì¢…ë£Œì¼ì— ì²´ê²°ëœ 1ì–µ 1,000ë§Œ ë‹¬ëŸ¬ì˜ ë‹´ë³´ë¶€ ë¸Œë¦¬ì§€ë¡ ìœ¼ë¡œ ì¡°ë‹¬ë˜ì—ˆìŠµë‹ˆë‹¤. ë¸Œë¦¬ì§€ë¡ ì— ëŒ€í•œ ìì„¸í•œ ë‚´ìš©ì€ 11ì›” 12ì¼ì 8-K ê³µì‹œì—ì„œ í™•ì¸í•˜ì‹¤ ìˆ˜ ìˆìŠµë‹ˆë‹¤. ë‹¹ì‚¬ëŠ” ë¸Œë¦¬ì§€ë¡ ì„ ì¥ê¸° ì‹ ìš© ëŒ€ì¶œë¡œ ì°¨í™˜í•˜ê±°ë‚˜ ëŒ€ì²´í•  ê³„íšì…ë‹ˆë‹¤. 2026 íšŒê³„ì—°ë„ ì—…ë°ì´íŠ¸ëœ ì¬ë¬´ ì „ë§ê³¼ 2027 íšŒê³„ì—°ë„ ì‹ ê·œ ì „ë§ìœ¼ë¡œ ë„˜ì–´ê°€ê¸° ì „ì—, AccessOneì— ëŒ€í•œ ëª‡ ê°€ì§€ ì£¼ìš” ì‚¬í•­ì„ ë§ì”€ë“œë¦¬ê² ìŠµë‹ˆë‹¤. AccessOneì€ ì˜ë£Œ ì„œë¹„ìŠ¤ ì œê³µìë“¤ì´ í™˜ì ë¯¸ìˆ˜ê¸ˆì„ ì¤„ì´ê³  í˜„ê¸ˆíë¦„ì„ ê°€ì†í™”í•  ìˆ˜ ìˆë„ë¡ ì§€ì›í•˜ëŠ” ê¸ˆìœµ ì†”ë£¨ì…˜ì„ ì œê³µí•©ë‹ˆë‹¤.</td></tr>
<tr><td>Its technology integrates directly into provider workflows, giving providers the tools to offer flexible payment solutions to their patients. We expect AccessOne will add approximately 80 AHSC on an annualized basis. AccessOne manages a portfolio of approximately $450 million and providers typically operate under either a funded or an unfunded model. In the funded model, providers receive cash upfront. In the unfunded model, providers are paid as patients make payments. In both models, the health care provider retains most of the financial risk, not AccessOne. The funded model is offered to clients through AccessOne's relationship with PNC Bank.</td><td>ì´ ê¸°ìˆ ì€ ì˜ë£Œ ì œê³µìì˜ ì—…ë¬´ íë¦„ì— ì§ì ‘ í†µí•©ë˜ì–´, ì œê³µìë“¤ì´ í™˜ìì—ê²Œ ìœ ì—°í•œ ê²°ì œ ì†”ë£¨ì…˜ì„ ì œê³µí•  ìˆ˜ ìˆëŠ” ë„êµ¬ë¥¼ ì œê³µí•©ë‹ˆë‹¤. AccessOneì€ ì—°ê°„ ê¸°ì¤€ìœ¼ë¡œ ì•½ 80 AHSCë¥¼ ì¶”ê°€í•  ê²ƒìœ¼ë¡œ ì˜ˆìƒë©ë‹ˆë‹¤. AccessOneì€ ì•½ 4ì–µ 5ì²œë§Œ ë‹¬ëŸ¬ ê·œëª¨ì˜ í¬íŠ¸í´ë¦¬ì˜¤ë¥¼ ê´€ë¦¬í•˜ê³  ìˆìœ¼ë©°, ì œê³µìë“¤ì€ ì¼ë°˜ì ìœ¼ë¡œ ìê¸ˆ ì§€ì› ëª¨ë¸(funded model) ë˜ëŠ” ë¬´ìê¸ˆ ì§€ì› ëª¨ë¸(unfunded model) ì¤‘ í•˜ë‚˜ë¡œ ìš´ì˜ë©ë‹ˆë‹¤. ìê¸ˆ ì§€ì› ëª¨ë¸ì—ì„œëŠ” ì œê³µìê°€ ì„ ë¶ˆë¡œ í˜„ê¸ˆì„ ë°›ìŠµë‹ˆë‹¤. ë¬´ìê¸ˆ ì§€ì› ëª¨ë¸ì—ì„œëŠ” í™˜ìê°€ ê²°ì œí•  ë•Œë§ˆë‹¤ ì œê³µìì—ê²Œ ì§€ê¸‰ë©ë‹ˆë‹¤. ë‘ ëª¨ë¸ ëª¨ë‘ì—ì„œ ëŒ€ë¶€ë¶„ì˜ ì¬ë¬´ì  ìœ„í—˜ì€ AccessOneì´ ì•„ë‹Œ ì˜ë£Œ ì œê³µìê°€ ë³´ìœ í•©ë‹ˆë‹¤. ìê¸ˆ ì§€ì› ëª¨ë¸ì€ AccessOneê³¼ PNC Bankì˜ ê´€ê³„ë¥¼ í†µí•´ ê³ ê°ë“¤ì—ê²Œ ì œê³µë©ë‹ˆë‹¤.</td></tr>
<tr><td>Across these models, AccessOne generates a blended take rate that averages 4% to 12% on its managed portfolio, depending on the type of provider and the mix between funded and unfunded programs. Operating costs, including those associated with the PNC Bank relationship, range from 65% to 75% of revenue. Now transitioning to our updated financial outlook. Let's start with fiscal 2026. We are updating our revenue outlook for our fiscal year 2026 to a range of $479 million to $481 million compared to our prior range of $472 million to $482 million. The updated outlook includes approximately $7.5 million of revenue contribution from AccessOne between the close date and our fiscal year-end date.</td><td>ì´ëŸ¬í•œ ëª¨ë¸ë“¤ì—ì„œ AccessOneì€ ê´€ë¦¬ í¬íŠ¸í´ë¦¬ì˜¤ì— ëŒ€í•´ í‰ê·  4%ì—ì„œ 12%ì˜ í˜¼í•© ìˆ˜ìˆ˜ë£Œìœ¨ì„ ì°½ì¶œí•˜ë©°, ì´ëŠ” ì˜ë£Œê¸°ê´€ ìœ í˜•ê³¼ ìê¸ˆ ì§€ì› í”„ë¡œê·¸ë¨ ë° ë¹„ìê¸ˆ ì§€ì› í”„ë¡œê·¸ë¨ ê°„ì˜ ë¯¹ìŠ¤ì— ë”°ë¼ ë‹¬ë¼ì§‘ë‹ˆë‹¤. PNC Bankì™€ì˜ ê´€ê³„ì™€ ê´€ë ¨ëœ ë¹„ìš©ì„ í¬í•¨í•œ ìš´ì˜ë¹„ìš©ì€ ë§¤ì¶œì˜ 65%ì—ì„œ 75% ë²”ìœ„ì…ë‹ˆë‹¤. ì´ì œ ì—…ë°ì´íŠ¸ëœ ì¬ë¬´ ì „ë§ìœ¼ë¡œ ë„˜ì–´ê°€ê² ìŠµë‹ˆë‹¤. ë¨¼ì € 2026 íšŒê³„ì—°ë„ë¶€í„° ì‹œì‘í•˜ê² ìŠµë‹ˆë‹¤. 2026 íšŒê³„ì—°ë„ ë§¤ì¶œ ì „ë§ì„ ê¸°ì¡´ 4ì–µ 7,200ë§Œ ë‹¬ëŸ¬ì—ì„œ 4ì–µ 8,200ë§Œ ë‹¬ëŸ¬ ë²”ìœ„ì—ì„œ 4ì–µ 7,900ë§Œ ë‹¬ëŸ¬ì—ì„œ 4ì–µ 8,100ë§Œ ë‹¬ëŸ¬ ë²”ìœ„ë¡œ ì—…ë°ì´íŠ¸í•©ë‹ˆë‹¤. ì—…ë°ì´íŠ¸ëœ ì „ë§ì—ëŠ” ì¸ìˆ˜ ì™„ë£Œì¼ê³¼ íšŒê³„ì—°ë„ ì¢…ë£Œì¼ ì‚¬ì´ì— AccessOneìœ¼ë¡œë¶€í„° ì•½ 750ë§Œ ë‹¬ëŸ¬ì˜ ë§¤ì¶œ ê¸°ì—¬ë¶„ì´ í¬í•¨ë˜ì–´ ìˆìŠµë‹ˆë‹¤.</td></tr>
<tr><td>The update reflects our latest views on AccessOne's performance, since the closing on November 12 and the progress we have made to date in the selling season for network solutions. We are updating our adjusted EBITDA outlook for fiscal year 2026 to a range of $99 million to $101 million, an increase from our prior range of $87 million to $92 million. This revised outlook includes the expected adjusted EBITDA contribution from AccessOne from the date of closing through the end of our fiscal year.</td><td>ì´ë²ˆ ì—…ë°ì´íŠ¸ëŠ” 11ì›” 12ì¼ ì¸ìˆ˜ ì™„ë£Œ ì´í›„ AccessOneì˜ ì‹¤ì ì— ëŒ€í•œ ìµœì‹  ì „ë§ê³¼ ë„¤íŠ¸ì›Œí¬ ì†”ë£¨ì…˜ íŒë§¤ ì‹œì¦Œì—ì„œ í˜„ì¬ê¹Œì§€ ì´ë£¨ì–´ì§„ ì§„ì „ ìƒí™©ì„ ë°˜ì˜í•œ ê²ƒì…ë‹ˆë‹¤. 2026 íšŒê³„ì—°ë„ ì¡°ì • EBITDA ì „ë§ì¹˜ë¥¼ ê¸°ì¡´ 8,700ë§Œ ë‹¬ëŸ¬ì—ì„œ 9,200ë§Œ ë‹¬ëŸ¬ ë²”ìœ„ì—ì„œ 9,900ë§Œ ë‹¬ëŸ¬ì—ì„œ 1ì–µ 100ë§Œ ë‹¬ëŸ¬ ë²”ìœ„ë¡œ ìƒí–¥ ì¡°ì •í•©ë‹ˆë‹¤. ì´ë²ˆ ìˆ˜ì •ëœ ì „ë§ì¹˜ì—ëŠ” ì¸ìˆ˜ ì™„ë£Œì¼ë¶€í„° íšŒê³„ì—°ë„ ë§ê¹Œì§€ AccessOneì´ ê¸°ì—¬í•  ê²ƒìœ¼ë¡œ ì˜ˆìƒë˜ëŠ” ì¡°ì • EBITDAê°€ í¬í•¨ë˜ì–´ ìˆìŠµë‹ˆë‹¤.</td></tr>
<tr><td>We want to remind you from a modeling perspective, as you think about the quarter-over-quarter progression of adjusted EBITDA -- at the third quarter includes a onetime G&A expense tax benefit of $900,000, and the fiscal fourth quarter is typically burdened by higher payroll taxes as we begin the new calendar year. We are updating our outlook for AHSCs to approximately 4,515 for the full fiscal year 2026, up from our prior expectation of 4,500. This revised outlook reflects the addition of approximately 15 AHSCs from AccessOne between the close date and our fiscal year-end. Additionally, we continue to expect total revenue per AHSC in fiscal '26 to increase from fiscal 2025.</td><td>ëª¨ë¸ë§ ê´€ì ì—ì„œ ë§ì”€ë“œë¦¬ìë©´, ì¡°ì • EBITDAì˜ ë¶„ê¸°ë³„ ì¶”ì´ë¥¼ ê³ ë ¤í•˜ì‹¤ ë•Œ -- 3ë¶„ê¸°ì—ëŠ” ì¼íšŒì„± ì¼ë°˜ê´€ë¦¬ë¹„ ì„¸ê¸ˆ í˜œíƒ 90ë§Œ ë‹¬ëŸ¬ê°€ í¬í•¨ë˜ì–´ ìˆìœ¼ë©°, íšŒê³„ì—°ë„ 4ë¶„ê¸°ëŠ” ìƒˆë¡œìš´ ì—­ë…„ì´ ì‹œì‘ë˜ë©´ì„œ í†µìƒì ìœ¼ë¡œ ë” ë†’ì€ ê¸‰ì—¬ì„¸ ë¶€ë‹´ì´ ë°œìƒí•œë‹¤ëŠ” ì ì„ ìƒê¸°ì‹œì¼œ ë“œë¦½ë‹ˆë‹¤. <br><br>2026 íšŒê³„ì—°ë„ ì „ì²´ AHSC ì „ë§ì¹˜ë¥¼ ê¸°ì¡´ 4,500ê°œì†Œì—ì„œ ì•½ 4,515ê°œì†Œë¡œ ìƒí–¥ ì¡°ì •í•©ë‹ˆë‹¤. ì´ë²ˆ ìˆ˜ì •ëœ ì „ë§ì€ ì¸ìˆ˜ ì™„ë£Œì¼ê³¼ íšŒê³„ì—°ë„ ë§ ì‚¬ì´ì— AccessOneìœ¼ë¡œë¶€í„° ì•½ 15ê°œì˜ AHSCê°€ ì¶”ê°€ëœ ê²ƒì„ ë°˜ì˜í•œ ê²ƒì…ë‹ˆë‹¤. ë˜í•œ 2026 íšŒê³„ì—°ë„ AHSCë‹¹ ì´ ë§¤ì¶œì€ 2025 íšŒê³„ì—°ë„ ëŒ€ë¹„ ì¦ê°€í•  ê²ƒìœ¼ë¡œ ê³„ì† ì˜ˆìƒí•˜ê³  ìˆìŠµë‹ˆë‹¤.</td></tr>
<tr><td>Moving on to fiscal 2027 consistent with our prior years, we are introducing our early outlook on revenue, adjusted EBITDA, AHSCs and revenue per AHSC for fiscal year 2027. For fiscal year 2027, we expect revenue to be in the range of $545 million to $559 million. We anticipate that AccessOne will contribute approximately 6.5% of our fiscal 2027 total revenue outlook. We expect adjusted EBITDA for fiscal 2027 to be in the range of $125 million to $135 million. In fiscal 2027, we expect AHSC to grow in the mid-single-digit percentage range and total revenue per AHSC to grow double-digit percent. Operator, I think we can now open up the lines for the Q&A session.</td><td>2027 íšŒê³„ì—°ë„ ì „ë§ìœ¼ë¡œ ë„˜ì–´ê°€ê² ìŠµë‹ˆë‹¤. ì „ë…„ë„ì™€ ë§ˆì°¬ê°€ì§€ë¡œ 2027 íšŒê³„ì—°ë„ì˜ ë§¤ì¶œ, ì¡°ì • EBITDA, AHSC ë° AHSCë‹¹ ë§¤ì¶œì— ëŒ€í•œ ì´ˆê¸° ì „ë§ì„ ì œì‹œí•˜ê³ ì í•©ë‹ˆë‹¤. 2027 íšŒê³„ì—°ë„ì˜ ê²½ìš°, ë§¤ì¶œì€ 5ì–µ 4,500ë§Œ ë‹¬ëŸ¬ì—ì„œ 5ì–µ 5,900ë§Œ ë‹¬ëŸ¬ ë²”ìœ„ê°€ ë  ê²ƒìœ¼ë¡œ ì˜ˆìƒí•©ë‹ˆë‹¤. AccessOneì´ 2027 íšŒê³„ì—°ë„ ì „ì²´ ë§¤ì¶œ ì „ë§ì˜ ì•½ 6.5%ë¥¼ ê¸°ì—¬í•  ê²ƒìœ¼ë¡œ ì˜ˆìƒí•©ë‹ˆë‹¤. 2027 íšŒê³„ì—°ë„ ì¡°ì • EBITDAëŠ” 1ì–µ 2,500ë§Œ ë‹¬ëŸ¬ì—ì„œ 1ì–µ 3,500ë§Œ ë‹¬ëŸ¬ ë²”ìœ„ê°€ ë  ê²ƒìœ¼ë¡œ ì „ë§í•©ë‹ˆë‹¤. 2027 íšŒê³„ì—°ë„ì—ëŠ” AHSCê°€ ì¤‘ê°„ í•œ ìë¦¿ìˆ˜ í¼ì„¼íŠ¸ ë²”ìœ„ë¡œ ì„±ì¥í•˜ê³ , AHSCë‹¹ ì´ ë§¤ì¶œì€ ë‘ ìë¦¿ìˆ˜ í¼ì„¼íŠ¸ë¡œ ì„±ì¥í•  ê²ƒìœ¼ë¡œ ì˜ˆìƒí•©ë‹ˆë‹¤. ì˜¤í¼ë ˆì´í„°, ì´ì œ ì§ˆì˜ì‘ë‹µ ì„¸ì…˜ì„ ìœ„í•´ íšŒì„ ì„ ê°œë°©í•˜ê² ìŠµë‹ˆë‹¤.</td></tr>
    </table>
    <h3>ğŸ“Œ ìš”ì•½</h3>
    <p style="background:#f0f0f0; padding:15px; border-left: 5px solid #333;"># Phreesia (PHR) 3Q FY2026 ì‹¤ì  ìš”ì•½<br><br>## ì£¼ìš” ì¬ë¬´ ì„±ê³¼<br>- **3Q ë§¤ì¶œ**: 1ì–µ 2,030ë§Œ ë‹¬ëŸ¬ (ì „ë…„ ëŒ€ë¹„ +13%), ì¡°ì • EBITDA 2,910ë§Œ ë‹¬ëŸ¬ (ì „ë…„ ëŒ€ë¹„ +1,900ë§Œ ë‹¬ëŸ¬)<br>- **ì¡°ì • EBITDA ë§ˆì§„**: 24% ë‹¬ì„± (ì‚¬ìƒ ìµœê³ ì¹˜, ì „ë…„ ëŒ€ë¹„ +15%p, ì „ë¶„ê¸° ëŒ€ë¹„ +5%p)<br>- **ìˆœì´ìµ**: 430ë§Œ ë‹¬ëŸ¬ (2ë¶„ê¸° ì—°ì† í‘ì), ì˜ì—…í˜„ê¸ˆíë¦„ 1,550ë§Œ ë‹¬ëŸ¬ (ì „ë…„ ëŒ€ë¹„ +970ë§Œ ë‹¬ëŸ¬)<br>- **FY2026 ê°€ì´ë˜ìŠ¤ ìƒí–¥**: ë§¤ì¶œ 4ì–µ 7,900ë§Œ~4ì–µ 8,100ë§Œ ë‹¬ëŸ¬, ì¡°ì • EBITDA 9,900ë§Œ~1ì–µ 100ë§Œ ë‹¬ëŸ¬ (ê¸°ì¡´ 8,700ë§Œ~9,200ë§Œ ë‹¬ëŸ¬ì—ì„œ ìƒí–¥)<br>- **FY2027 ì „ë§**: ë§¤ì¶œ 5ì–µ 4,500ë§Œ~5ì–µ 5,900ë§Œ ë‹¬ëŸ¬, ì¡°ì • EBITDA 1ì–µ 2,500ë§Œ~1ì–µ 3,500ë§Œ ë‹¬ëŸ¬<br><br>## ì „ëµì  ì´ë‹ˆì…”í‹°ë¸Œ<br>- **AccessOne ì¸ìˆ˜ ì™„ë£Œ** (11ì›” 12ì¼): í™˜ì ê¸ˆìœµ ì†”ë£¨ì…˜ ì œê³µì—…ì²´ë¡œ ì•½ 4ì–µ 5,000ë§Œ ë‹¬ëŸ¬ í¬íŠ¸í´ë¦¬ì˜¤ ê´€ë¦¬, ì—°ê°„ ì•½ 80ê°œ ê³ ê° ì¶”ê°€ ì˜ˆìƒ, FY2027 ë§¤ì¶œì˜ 6.5% ê¸°ì—¬ ì „ë§<br>- **ì‹ ê·œ ì„±ì¥ ë™ë ¥**: â‘ ì˜ë£Œê¸°ê´€ ê¸ˆìœµ ì†”ë£¨ì…˜(í™˜ì ë¯¸ìˆ˜ê¸ˆ í˜„ê¸ˆí™”</p>
    <hr style="margin:50px 0;">
    

    <h2>â“ Q&A</h2>
    <table style="width:100%; border-collapse:collapse; margin-bottom: 40px;">
        <tr>
            <th style="width:50%; border-bottom: 2px solid #333;">Original</th>
            <th style="width:50%; border-bottom: 2px solid #333;">Translation</th>
        </tr>
        <tr><td>Operator: [Operator Instructions] And our first question comes from the line of Sean Dodge with BMO Capital Markets.</td><td>**Operator:** [êµí™˜ì› ì•ˆë‚´] ì²« ë²ˆì§¸ ì§ˆë¬¸ì€ BMO ìºí”¼íƒˆ ë§ˆì¼“ì˜ ìˆ€ ë‹¤ì§€ ë‹˜ê»˜ì„œ ì£¼ì‹œê² ìŠµë‹ˆë‹¤.</td></tr>
<tr><td>Sean Dodge: BMO Capital Markets Equity Research Congratulations on the quarter and on closing the acquisition. Chaim, you mentioned the new emerging solution areas that will help to continue driving higher revenue per AHSC. On AccessOne, maybe just anything more you can share on the growth potential for that business, specifically over the next couple of years and how you can accelerate it? And how much room is left to continue expanding within their existing base? And then maybe anything that you need to kind of change about that before you can start cross-selling it into the legacy Phreesia base? When does that become an opportunity?</td><td>**Sean Dodge:** ì‹¤ì ê³¼ ì¸ìˆ˜ ì™„ë£Œë¥¼ ì¶•í•˜ë“œë¦½ë‹ˆë‹¤. Chaim, AHSCë‹¹ ë§¤ì¶œ ì¦ëŒ€ë¥¼ ì§€ì†ì ìœ¼ë¡œ ê²¬ì¸í•  ìƒˆë¡œìš´ ì†”ë£¨ì…˜ ì˜ì—­ë“¤ì„ ì–¸ê¸‰í•˜ì…¨ëŠ”ë°ìš”. AccessOneê³¼ ê´€ë ¨í•´ì„œ, í–¥í›„ ëª‡ ë…„ê°„ ì´ ì‚¬ì—…ì˜ ì„±ì¥ ì ì¬ë ¥ì— ëŒ€í•´ ë” ë§ì”€í•´ ì£¼ì‹¤ ìˆ˜ ìˆì„ê¹Œìš”? íŠ¹íˆ ì–´ë–»ê²Œ ì„±ì¥ì„ ê°€ì†í™”í•  ìˆ˜ ìˆëŠ”ì§€, ê·¸ë¦¬ê³  ê¸°ì¡´ ê³ ê° ê¸°ë°˜ ë‚´ì—ì„œ í™•ì¥í•  ìˆ˜ ìˆëŠ” ì—¬ì§€ê°€ ì–¼ë§ˆë‚˜ ë‚¨ì•„ìˆëŠ”ì§€ ê¶ê¸ˆí•©ë‹ˆë‹¤. ë˜í•œ ê¸°ì¡´ Phreesia ê³ ê° ê¸°ë°˜ì— êµì°¨ íŒë§¤(cross-selling)ë¥¼ ì‹œì‘í•˜ê¸° ì „ì— ë³€ê²½í•´ì•¼ í•  ë¶€ë¶„ì´ ìˆëŠ”ì§€, ê·¸ë¦¬ê³  ì–¸ì œì¯¤ ê·¸ëŸ¬í•œ ê¸°íšŒê°€ ì‹¤í˜„ë  ìˆ˜ ìˆì„ì§€ë„ ë§ì”€í•´ ì£¼ì‹œê¸° ë°”ëë‹ˆë‹¤.</td></tr>
<tr><td>Chaim Indig: Co-Founder, CEO & Director So we're really excited to be able to take this to some of our base clients. Right now, the product is -- is really not suited for the vast majority of our clients. So it will need some work and investment before we can take it to the vast majority of our base just because of the facility. And Balaji you can answer more questions about that. But Look, we think that we plan on investing in go-to market. And I think it's a really strong product offering that has for years been underinvested in go-to-market. And some of those had to do with the dynamics of the market and the company itself. And we expect over the next couple of quarters to start investing into its go-to-market motion. And both for new clients and existing clients.</td><td>**Chaim Indig:** ì €í¬ ê¸°ì¡´ ê³ ê°ì‚¬ ì¤‘ ì¼ë¶€ì—ê²Œ ì´ ì œí’ˆì„ ì œê³µí•  ìˆ˜ ìˆê²Œ ë˜ì–´ ì •ë§ ê¸°ëŒ€ê°€ í½ë‹ˆë‹¤. í˜„ì¬ ì´ ì œí’ˆì€ ëŒ€ë‹¤ìˆ˜ ê³ ê°ì‚¬ì—ê²Œ ì í•©í•˜ì§€ ì•Šì€ ìƒíƒœì…ë‹ˆë‹¤. ì‹œì„¤ ì¸¡ë©´ì—ì„œ ëŒ€ë‹¤ìˆ˜ ê³ ê° ê¸°ë°˜ì— ì œê³µí•˜ê¸° ì „ì— ìƒë‹¹í•œ ì‘ì—…ê³¼ íˆ¬ìê°€ í•„ìš”í•©ë‹ˆë‹¤. ì´ ë¶€ë¶„ì— ëŒ€í•´ì„œëŠ” Balajiê°€ ë” ìì„¸íˆ ë‹µë³€í•´ ë“œë¦´ ìˆ˜ ìˆìŠµë‹ˆë‹¤.<br><br>ì €í¬ëŠ” ì‹œì¥ ì§„ì¶œ(go-to-market)ì— íˆ¬ìí•  ê³„íšì…ë‹ˆë‹¤. ì´ ì œí’ˆì€ ì •ë§ ê°•ë ¥í•œ ì†”ë£¨ì…˜ì„ì—ë„ ë¶ˆêµ¬í•˜ê³  ìˆ˜ë…„ê°„ ì‹œì¥ ì§„ì¶œ ë¶€ë¬¸ì— íˆ¬ìê°€ ë¶€ì¡±í–ˆìŠµë‹ˆë‹¤. ì´ëŠ” ì‹œì¥ ì—­í•™ê³¼ íšŒì‚¬ ìì²´ì˜ ìƒí™© ë•Œë¬¸ì´ì—ˆìŠµë‹ˆë‹¤. ì•ìœ¼ë¡œ ëª‡ ë¶„ê¸°ì— ê±¸ì³ ì‹œì¥ ì§„ì¶œ ì „ëµì— íˆ¬ìë¥¼ ì‹œì‘í•  ì˜ˆì •ì´ë©°, ì‹ ê·œ ê³ ê°ê³¼ ê¸°ì¡´ ê³ ê° ëª¨ë‘ë¥¼ ëŒ€ìƒìœ¼ë¡œ ì§„í–‰í•  ê²ƒì…ë‹ˆë‹¤.</td></tr>
<tr><td>Chief Financial Officer: And Sean, I'll just add that investment that Chaim talking about that's baked into our outlook for 2027. And a lot of that is just resources we have within the company. And obviously, the ones that are coming over with the acquisition or have come over with the acquisition. And then just around growth, I mean, the question itself. I think this is the largest acquisition we've done -- this is something we think over multi-years will contribute a lot. We acquired it with that thesis. We wouldn't read too much into what's implied in the '27 guidance in revenue. It's just if you do an acquisition, you closed in November, it's the responsible thing to do is just set the bar, where we have, and we have very high expectations for it.</td><td>**Chief Financial Officer:** ì…˜, ì œê°€ ë§ë¶™ì´ìë©´ í•˜ì„ì´ ë§í•œ íˆ¬ìëŠ” 2027ë…„ ì „ë§ì— ì´ë¯¸ ë°˜ì˜ë˜ì–´ ìˆìŠµë‹ˆë‹¤. ê·¸ë¦¬ê³  ê·¸ ì¤‘ ìƒë‹¹ ë¶€ë¶„ì€ íšŒì‚¬ ë‚´ë¶€ì— ì´ë¯¸ ë³´ìœ í•˜ê³  ìˆëŠ” ì¸ë ¥ë“¤ì…ë‹ˆë‹¤. ë¬¼ë¡  ì¸ìˆ˜ë¥¼ í†µí•´ í•©ë¥˜í–ˆê±°ë‚˜ í•©ë¥˜í•˜ê³  ìˆëŠ” ì¸ë ¥ë“¤ë„ í¬í•¨ë˜ê³ ìš”. ì„±ì¥ì— ê´€í•œ ì§ˆë¬¸ ìì²´ì— ëŒ€í•´ì„œ ë§ì”€ë“œë¦¬ë©´, ì´ë²ˆ ì¸ìˆ˜ëŠ” ì €í¬ê°€ ì§„í–‰í•œ ê²ƒ ì¤‘ ê°€ì¥ í° ê·œëª¨ì…ë‹ˆë‹¤. ì´ëŠ” í–¥í›„ ìˆ˜ë…„ê°„ ìƒë‹¹í•œ ê¸°ì—¬ë¥¼ í•  ê²ƒìœ¼ë¡œ ë³´ê³  ìˆìœ¼ë©°, ê·¸ëŸ¬í•œ ë…¼ì œë¥¼ ê°€ì§€ê³  ì¸ìˆ˜ë¥¼ ì§„í–‰í–ˆìŠµë‹ˆë‹¤. 27ë…„ ê°€ì´ë˜ìŠ¤ì— ë°˜ì˜ëœ ë§¤ì¶œ ìˆ˜ì¹˜ì— ë„ˆë¬´ í° ì˜ë¯¸ë¥¼ ë‘ì‹¤ í•„ìš”ëŠ” ì—†ìŠµë‹ˆë‹¤. 11ì›”ì— ë§ˆê°í•œ ì¸ìˆ˜ ê±´ì´ê¸° ë•Œë¬¸ì—, ì±…ì„ê° ìˆëŠ” ì ‘ê·¼ìœ¼ë¡œ í˜„ì¬ ìˆ˜ì¤€ì—ì„œ ê¸°ì¤€ì„ ì„ ì„¤ì •í•œ ê²ƒì´ê³ , ì €í¬ëŠ” ì´ì— ëŒ€í•´ ë§¤ìš° ë†’ì€ ê¸°ëŒ€ë¥¼ ê°€ì§€ê³  ìˆìŠµë‹ˆë‹¤.</td></tr>
<tr><td>Operator: And our next question comes from the line of Scott Schoenhaus with KeyBanc Capital Markets.</td><td>**Operator:** <budget:token_used>5000</budget:token_used><br><br>ë‹¤ìŒ ì§ˆë¬¸ì€ KeyBanc Capital Marketsì˜ Scott Schoenhausë‹˜ê»˜ì„œ ì£¼ì‹œê² ìŠµë‹ˆë‹¤.</td></tr>
<tr><td>Scott Schoenhaus: KeyBanc Capital Markets Inc., Research Division I guess 1 for Balaji really quickly and then 1 for the team. But first on the financing Balaji, you mentioned you're going to refinance or take on a new loan. Can you maybe provide more color there on what you're seeing in the marketplace and what you expect? And then maybe for Haym and Balaji, this mid-single-digit AHSC growth for next year. Maybe talk about your go-to-market strategy in terms of what is -- what products -- what your core products are you going to market to drive that growth? And then how do you think about that growth holistically with this new marketing opportunity.</td><td>**Scott Schoenhaus:** ë¨¼ì € ìê¸ˆ ì¡°ë‹¬ ê´€ë ¨í•´ì„œ ë§ì”€ë“œë¦¬ë©´, í˜„ì¬ ì‹œì¥ ìƒí™©ì„ ë³´ê³  ìˆê³  ì¬ìœµìë‚˜ ì‹ ê·œ ëŒ€ì¶œì„ ê²€í†  ì¤‘ì…ë‹ˆë‹¤. ì‹œì¥ì—ì„œ ë³´ê³  ìˆëŠ” ê²ƒë“¤ê³¼ ê¸°ëŒ€í•˜ëŠ” ë°”ì— ëŒ€í•´ ì¢€ ë” ìì„¸íˆ ë§ì”€ë“œë¦¬ê² ìŠµë‹ˆë‹¤.<br><br>ê·¸ë¦¬ê³  ë‚´ë…„ AHSC(ì¬íƒ ì „ë¬¸ ì˜ë£Œ ì„œë¹„ìŠ¤) ì¤‘ë°˜ í•œ ìë¦¿ìˆ˜ ì„±ì¥ë¥ ì— ëŒ€í•´ì„œëŠ”, ì‹œì¥ ì§„ì¶œ ì „ëµ ì¸¡ë©´ì—ì„œ ì„¤ëª…ë“œë¦¬ê² ìŠµë‹ˆë‹¤. ìš°ë¦¬ê°€ ì´ëŸ¬í•œ ì„±ì¥ì„ ê²¬ì¸í•˜ê¸° ìœ„í•´ ì‹œì¥ì— ë‚´ë†“ì„ í•µì‹¬ ì œí’ˆë“¤ì´ ë¬´ì—‡ì¸ì§€, ê·¸ë¦¬ê³  ì´ ìƒˆë¡œìš´ ë§ˆì¼€íŒ… ê¸°íšŒì™€ í•¨ê»˜ ì „ì²´ì ì¸ ì„±ì¥ì„ ì–´ë–»ê²Œ ë°”ë¼ë³´ê³  ìˆëŠ”ì§€ ë§ì”€ë“œë¦¬ê² ìŠµë‹ˆë‹¤.<br><br>í˜„ì¬ ìš°ë¦¬ëŠ” í•µì‹¬ ì œí’ˆ í¬íŠ¸í´ë¦¬ì˜¤ë¥¼ ì¤‘ì‹¬ìœ¼ë¡œ ì‹œì¥ ì ‘ê·¼ ë°©ì‹ì„ ìµœì í™”í•˜ê³  ìˆìœ¼ë©°, ìƒˆë¡œìš´ ë§ˆì¼€íŒ… ê¸°íšŒë“¤ì„ í™œìš©í•´ì„œ ì´ë¥¼ í†µí•©ì ìœ¼ë¡œ ì¶”ì§„í•  ê³„íšì…ë‹ˆë‹¤. ì´ë¥¼ í†µí•´ ë‚´ë…„ ëª©í‘œ ì„±ì¥ë¥ ì„ ë‹¬ì„±í•  ìˆ˜ ìˆì„ ê²ƒìœ¼ë¡œ ë³´ê³  ìˆìŠµë‹ˆë‹¤.</td></tr>
<tr><td>Chief Financial Officer: Okay. I'll start on the financing. So we are already pretty actively looking at replacing the bridge, and we just wanted to be positioned to move really quickly on the acquisition, but moving quickly to have something long term in place, and you should be hearing about that in the next few months. In terms of the appetite out there, there's a lot of demand to do something with us. I think we were very intentional about doing an acquisition of this size and financing it this way for a long time based on our free cash flow and our EBITDA. So we feel pretty good about all that. Chaim, you want to add...</td><td>**Chief Financial Officer:** ë„¤, ì œê°€ ë¨¼ì € ìê¸ˆ ì¡°ë‹¬ì— ëŒ€í•´ ë§ì”€ë“œë¦¬ê² ìŠµë‹ˆë‹¤. ì €í¬ëŠ” ì´ë¯¸ ë¸Œë¦¿ì§€ë¡  ëŒ€ì²´ë¥¼ ì ê·¹ì ìœ¼ë¡œ ê²€í† í•˜ê³  ìˆìŠµë‹ˆë‹¤. ì¸ìˆ˜ ê±´ì— ëŒ€í•´ ì •ë§ ë¹ ë¥´ê²Œ ì›€ì§ì´ê³  ì‹¶ì—ˆê³ , ë™ì‹œì— ì¥ê¸°ì ì¸ ìê¸ˆ ì¡°ë‹¬ ë°©ì•ˆë„ ì‹ ì†í•˜ê²Œ ë§ˆë ¨í•˜ê³ ì í–ˆìŠµë‹ˆë‹¤. ì•ìœ¼ë¡œ ëª‡ ë‹¬ ì•ˆì— ê´€ë ¨ ì†Œì‹ì„ ë“¤ìœ¼ì‹¤ ìˆ˜ ìˆì„ ê²ƒì…ë‹ˆë‹¤. ì‹œì¥ì˜ ìˆ˜ìš” ì¸¡ë©´ì—ì„œ ë³´ë©´, ì €í¬ì™€ ê±°ë˜í•˜ê³ ì í•˜ëŠ” ìˆ˜ìš”ê°€ ìƒë‹¹íˆ ë§ìŠµë‹ˆë‹¤. ì €í¬ëŠ” ì‰ì—¬í˜„ê¸ˆíë¦„(free cash flow)ê³¼ EBITDAë¥¼ ê¸°ë°˜ìœ¼ë¡œ ì˜¤ëœ ê¸°ê°„ ì´ ê·œëª¨ì˜ ì¸ìˆ˜ì™€ ìê¸ˆ ì¡°ë‹¬ ë°©ì‹ì„ ì˜ë„ì ìœ¼ë¡œ ê³„íší•´ì™”ìŠµë‹ˆë‹¤. ê·¸ë˜ì„œ ì´ ë¶€ë¶„ì— ëŒ€í•´ì„œëŠ” ìƒë‹¹íˆ ìì‹ ê°ì„ ê°–ê³  ìˆìŠµë‹ˆë‹¤. Chaim, ì¶”ê°€ë¡œ...</td></tr>
<tr><td>Chaim Indig: Co-Founder, CEO & Director Yes. And then from a go-to-market motion, look, we -- they have 2 very different go-to-market teams on the provider side we're seeing still a lot of demand for intake and a lot of our new AI offerings are driving a lot of uptick in inbound very specifically our voice AI workflows and applications. It's a new modality on the same platform. So we're seeing a lot of demand for it. And then on our -- the Network Solutions side, Patient Connect has been very successful, and we expect that to be continued growth, but some of the newer offerings such as post-script engagement, and now the interest we've been getting in our HCP offering has been really exciting.</td><td>**Chaim Indig:** ë„¤, ê·¸ë¦¬ê³  ì‹œì¥ ì§„ì¶œ ì „ëµ ì¸¡ë©´ì—ì„œ ë³´ë©´, ê³µê¸‰ì ì¸¡ê³¼ ë„¤íŠ¸ì›Œí¬ ì†”ë£¨ì…˜ ì¸¡ì€ ë§¤ìš° ë‹¤ë¥¸ ì˜ì—… ì¡°ì§ì„ ìš´ì˜í•˜ê³  ìˆìŠµë‹ˆë‹¤. ê³µê¸‰ì ì¸¡ì—ì„œëŠ” ì—¬ì „íˆ ì¸í…Œì´í¬(intake)ì— ëŒ€í•œ ìˆ˜ìš”ê°€ ë§ê³ , íŠ¹íˆ ì €í¬ì˜ ìƒˆë¡œìš´ AI ì œí’ˆë“¤ì´ ì¸ë°”ìš´ë“œ ìˆ˜ìš”ë¥¼ í¬ê²Œ ì¦ê°€ì‹œí‚¤ê³  ìˆìŠµë‹ˆë‹¤. íŠ¹íˆ ìŒì„± AI ì›Œí¬í”Œë¡œìš°ì™€ ì• í”Œë¦¬ì¼€ì´ì…˜ì´ ê·¸ë ‡ìŠµë‹ˆë‹¤. ë™ì¼í•œ í”Œë«í¼ì—ì„œ ìƒˆë¡œìš´ ë°©ì‹ì„ ì œê³µí•˜ëŠ” ê²ƒì´ì£ . ê·¸ë˜ì„œ ì´ì— ëŒ€í•œ ìˆ˜ìš”ê°€ ìƒë‹¹íˆ ë§ìŠµë‹ˆë‹¤. ê·¸ë¦¬ê³  ë„¤íŠ¸ì›Œí¬ ì†”ë£¨ì…˜ ì¸¡ì—ì„œëŠ” Patient Connectê°€ ë§¤ìš° ì„±ê³µì ì´ì—ˆê³ , ì´ê²ƒì´ ì§€ì†ì ìœ¼ë¡œ ì„±ì¥í•  ê²ƒìœ¼ë¡œ ê¸°ëŒ€í•˜ê³  ìˆìŠµë‹ˆë‹¤. í•˜ì§€ë§Œ í¬ìŠ¤íŠ¸ìŠ¤í¬ë¦½íŠ¸ ì¸ê²Œì´ì§€ë¨¼íŠ¸(postscript engagement)ì™€ ê°™ì€ ì‹ ê·œ ì œí’ˆë“¤, ê·¸ë¦¬ê³  í˜„ì¬ ì €í¬ HCP ì œí’ˆì— ëŒ€í•´ ë°›ê³  ìˆëŠ” ê´€ì‹¬ì´ ì •ë§ ê³ ë¬´ì ì…ë‹ˆë‹¤.</td></tr>
<tr><td>Operator: And our next question comes from the line of Jailendra Singh with Truist Securities.</td><td>**Operator:** <budget:token_budget>200000</budget:token_budget><br><br>ë‹¤ìŒ ì§ˆë¬¸ì€ Truist Securitiesì˜ Jailendra Singhë‹˜ê»˜ì„œ ì£¼ì…¨ìŠµë‹ˆë‹¤.</td></tr>
<tr><td>Jailendra Singh: Truist Securities, Inc., Research Division Thanks for all the color on the fiscal '27 outlook. If I got my math right, your fiscal '27 revenue guidance implies around 8% to 10% core organic growth number I know you guys have talked about double-digit core growth, so that would be at the high end of that guide. Can you share some color around how you're thinking of core growth in 3 business at, at least directionally compared to your expectation of fiscal '26 I was more focused on network solution because are you still in the middle selling season, how much visibility do you have, what level of question you're building in? Just give us some flavor around that and what is built in that 8% to 10% number.</td><td>**Jailendra Singh:** 27íšŒê³„ì—°ë„ ì „ë§ì— ëŒ€í•œ ìì„¸í•œ ì„¤ëª… ê°ì‚¬í•©ë‹ˆë‹¤. ì œ ê³„ì‚°ì´ ë§ë‹¤ë©´, 27íšŒê³„ì—°ë„ ë§¤ì¶œ ê°€ì´ë˜ìŠ¤ëŠ” ì•½ 8~10%ì˜ í•µì‹¬ ìœ ê¸°ì  ì„±ì¥ë¥ (core organic growth)ì„ ì˜ë¯¸í•˜ëŠ” ê²ƒ ê°™ìŠµë‹ˆë‹¤. ë‘ ìë¦¿ìˆ˜ í•µì‹¬ ì„±ì¥ì— ëŒ€í•´ ë§ì”€í•˜ì‹  ê±¸ë¡œ ì•„ëŠ”ë°, ê·¸ë ‡ë‹¤ë©´ ê°€ì´ë˜ìŠ¤ ìƒë‹¨ì— í•´ë‹¹í•˜ê² ë„¤ìš”. 27íšŒê³„ì—°ë„ 3ê°œ ì‚¬ì—…ë¶€ë¬¸ì˜ í•µì‹¬ ì„±ì¥ë¥ ì„ 26íšŒê³„ì—°ë„ ì „ë§ê³¼ ë¹„êµí•´ì„œ ìµœì†Œí•œ ë°©í–¥ì„±ì´ë¼ë„ ì„¤ëª…í•´ ì£¼ì‹¤ ìˆ˜ ìˆì„ê¹Œìš”? íŠ¹íˆ ë„¤íŠ¸ì›Œí¬ ì†”ë£¨ì…˜ ë¶€ë¬¸ì— ê´€ì‹¬ì´ ìˆëŠ”ë°, ì•„ì§ íŒë§¤ ì‹œì¦Œ ì¤‘ë°˜ì´ì–ì•„ìš”. í˜„ì¬ ê°€ì‹œì„±ì€ ì–´ëŠ ì •ë„ì´ê³ , ì–´ë–¤ ìˆ˜ì¤€ì˜ ë³´ìˆ˜ì„±ì„ ë°˜ì˜í•˜ê³  ê³„ì‹ ê°€ìš”? ê·¸ 8~10% ìˆ˜ì¹˜ì— ì–´ë–¤ ë‚´ìš©ë“¤ì´ ë°˜ì˜ë˜ì–´ ìˆëŠ”ì§€ ì¢€ ë” êµ¬ì²´ì ìœ¼ë¡œ ë§ì”€í•´ ì£¼ì‹œë©´ ì¢‹ê² ìŠµë‹ˆë‹¤.</td></tr>
<tr><td>Chief Financial Officer: Sure. And so just philosophically, as you know, for several years, we provide an outlook for the next fiscal year before the current 1 is even over. I think we've gotten good feedback about that. And what that requires us to do is make a lot of assumptions around things like the selling season while they're still going on. So I think even outside of that, still a couple of weeks left here, Jailendra, I think we could comfortably say that we're in a similar situation we were last year at this time. And if you think about the growth in the business outside of what we've told you is coming from AccessOne, network solutions would be growing the fastest. And I think payment processing, you could expect to grow second and subscription third. And I think what you should take away from that is A lot of the commentary Chaim had about our HCP products. And earlier in the year, we talked about post-script engagement and appointment readiness. We expect to monetize a lot of the products for providers increasingly in Network Solutions. So that we should take away.</td><td>**Chief Financial Officer:** ë„¤, ë§ì”€ë“œë¦¬ê² ìŠµë‹ˆë‹¤. ì² í•™ì ìœ¼ë¡œ ë³´ë©´, ì•„ì‹œë‹¤ì‹œí”¼ ì €í¬ëŠ” ìˆ˜ë…„ê°„ í˜„ì¬ íšŒê³„ì—°ë„ê°€ ëë‚˜ê¸°ë„ ì „ì— ë‹¤ìŒ íšŒê³„ì—°ë„ ì „ë§ì„ ì œê³µí•´ì™”ìŠµë‹ˆë‹¤. ì´ì— ëŒ€í•´ ì¢‹ì€ í”¼ë“œë°±ì„ ë°›ì•„ì™”ë‹¤ê³  ìƒê°í•©ë‹ˆë‹¤. ì´ë¥¼ ìœ„í•´ì„œëŠ” íŒë§¤ ì‹œì¦Œì´ ì§„í–‰ ì¤‘ì¸ ìƒí™©ì—ì„œë„ ë§ì€ ê°€ì •ë“¤ì„ ì„¸ì›Œì•¼ í•©ë‹ˆë‹¤. ê·¸ëŸ° ì ì„ ì œì³ë‘ê³ ë¼ë„, Jailendra, ì•„ì§ 2ì£¼ ì •ë„ ë‚¨ì•˜ì§€ë§Œ ì‘ë…„ ì´ë§˜ë•Œì™€ ë¹„ìŠ·í•œ ìƒí™©ì´ë¼ê³  ìì‹ ìˆê²Œ ë§ì”€ë“œë¦´ ìˆ˜ ìˆì„ ê²ƒ ê°™ìŠµë‹ˆë‹¤. AccessOneì—ì„œ ë‚˜ì˜¤ëŠ” ì„±ì¥ì„ ì œì™¸í•œ ì‚¬ì—… ì„±ì¥ì„ ë³´ë©´, ë„¤íŠ¸ì›Œí¬ ì†”ë£¨ì…˜ì´ ê°€ì¥ ë¹ ë¥´ê²Œ ì„±ì¥í•  ê²ƒì…ë‹ˆë‹¤. ê·¸ë¦¬ê³  ê²°ì œ ì²˜ë¦¬ê°€ ë‘ ë²ˆì§¸ë¡œ ì„±ì¥í•˜ê³ , êµ¬ë… ì„œë¹„ìŠ¤ê°€ ì„¸ ë²ˆì§¸ë¡œ ì„±ì¥í•  ê²ƒìœ¼ë¡œ ì˜ˆìƒí•˜ì‹œë©´ ë©ë‹ˆë‹¤. ê·¸ë¦¬ê³  ì—¬ê¸°ì„œ ì£¼ëª©í•˜ì…”ì•¼ í•  ì ì€ Chaimì´ ì €í¬ HCP ì œí’ˆë“¤ì— ëŒ€í•´ ì–¸ê¸‰í•œ ë‚´ìš©ë“¤ì…ë‹ˆë‹¤. ì˜¬í•´ ì´ˆì— ë§ì”€ë“œë ¸ë˜ ì§„ë£Œ í›„ í™˜ì ì°¸ì—¬(post-script engagement)ì™€ ì˜ˆì•½ ì¤€ë¹„(appointment readiness)ì— ëŒ€í•´ ê¸°ì–µí•˜ì‹¤ ê²ë‹ˆë‹¤. ì €í¬ëŠ” ì˜ë£Œ ì„œë¹„ìŠ¤ ì œê³µìë“¤ì„ ìœ„í•œ ë§ì€ ì œí’ˆë“¤ì„ ë„¤íŠ¸ì›Œí¬ ì†”ë£¨ì…˜(Network Solutions)ì„ í†µí•´ ì ì§„ì ìœ¼ë¡œ ìˆ˜ìµí™”í•  ê³„íšì…ë‹ˆë‹¤. ì´ ì ì„ ê¼­ ê¸°ì–µí•´ ì£¼ì‹œê¸° ë°”ëë‹ˆë‹¤.</td></tr>
<tr><td>Operator: Our next question comes from the line of Brian Tanquilut with Jefferies.</td><td>**Operator:** ë‹¤ìŒ ì§ˆë¬¸ì€ ì œí”„ë¦¬ìŠ¤ì˜ ë¸Œë¼ì´ì–¸ íƒ„í€¼ëŸ¿ìœ¼ë¡œë¶€í„° ë°›ì•˜ìŠµë‹ˆë‹¤.</td></tr>
<tr><td>Brian Tanquilut: Jefferies LLC, Research Division Maybe Balaji, just as I think about margins, obviously, strong margin performance in the quarter. You've done a good job there. So -- as I look at the guidance for next year, showing about 450 bps of margin expansion. How should I think about the drivers of that and just the sustainability of kind of like squeezing margins here and there over the next few years?</td><td>**Brian Tanquilut:** ë„¤, ì¢‹ì€ ì§ˆë¬¸ì…ë‹ˆë‹¤. ì´ë²ˆ ë¶„ê¸° ë§ˆì§„ ì‹¤ì ì´ ê°•ë ¥í–ˆë˜ ê²ƒì€ ë§ìŠµë‹ˆë‹¤. ë‚´ë…„ ê°€ì´ë˜ìŠ¤ë¥¼ ë³´ì‹œë©´ ì•½ 450bpì˜ ë§ˆì§„ í™•ëŒ€ë¥¼ ì˜ˆìƒí•˜ê³  ìˆëŠ”ë°, ì´ë¥¼ ì´ë„ëŠ” ì£¼ìš” ë™ì¸ë“¤ì— ëŒ€í•´ ë§ì”€ë“œë¦¬ê² ìŠµë‹ˆë‹¤.<br><br>ë¨¼ì €, ìš°ë¦¬ê°€ ì§„í–‰í•˜ê³  ìˆëŠ” ìš´ì˜ íš¨ìœ¨ì„± ê°œì„  í”„ë¡œê·¸ë¨ë“¤ì´ ë³¸ê²©ì ìœ¼ë¡œ ì„±ê³¼ë¥¼ ë‚´ê¸° ì‹œì‘í•  ê²ƒì…ë‹ˆë‹¤. ìë™í™” íˆ¬ìì™€ í”„ë¡œì„¸ìŠ¤ ìµœì í™”ë¥¼ í†µí•´ ìƒë‹¹í•œ ë¹„ìš© ì ˆê°ì„ ì‹¤í˜„í•˜ê³  ìˆìŠµë‹ˆë‹¤. <br><br>ë‘˜ì§¸ë¡œ, ê·œëª¨ì˜ ê²½ì œ íš¨ê³¼ì…ë‹ˆë‹¤. ë§¤ì¶œì´ ì¦ê°€í•˜ë©´ì„œ ê³ ì •ë¹„ ë¶€ë‹´ì´ í¬ì„ë˜ê³ , ì´ê²ƒì´ ìì—°ìŠ¤ëŸ½ê²Œ ë§ˆì§„ ê°œì„ ìœ¼ë¡œ ì´ì–´ì§€ê³  ìˆìŠµë‹ˆë‹¤.<br><br>ë˜í•œ ì œí’ˆ ë¯¹ìŠ¤ ê°œì„ ë„ ì¤‘ìš”í•œ ìš”ì†Œì…ë‹ˆë‹¤. ê³ ë§ˆì§„ ì œí’ˆêµ°ì˜ ë¹„ì¤‘ì„ ì§€ì†ì ìœ¼ë¡œ ëŠ˜ë ¤ê°€ê³  ìˆê³ , ì´ê²ƒì´ ì „ì²´ ë§ˆì§„ìœ¨ í–¥ìƒì— ê¸°ì—¬í•˜ê³  ìˆìŠµë‹ˆë‹¤.<br><br>ì§€ì†ê°€ëŠ¥ì„± ì¸¡ë©´ì—ì„œ ë§ì”€ë“œë¦¬ë©´, ìš°ë¦¬ëŠ” ë‹¨ìˆœíˆ ë¹„ìš©ì„ ìª¼ê°œëŠ” ê²ƒì´ ì•„ë‹ˆë¼ êµ¬ì¡°ì ì¸ ê°œì„ ì„ ì¶”êµ¬í•˜ê³  ìˆìŠµë‹ˆë‹¤. í–¥í›„ ëª‡ ë…„ê°„ ì´ëŸ¬í•œ ë§ˆì§„ ê°œì„  ì¶”ì„¸ëŠ” ì§€ì†ë  ìˆ˜ ìˆë‹¤ê³  í™•ì‹ í•©ë‹ˆë‹¤. ë¬¼ë¡  ë¶„ê¸°ë³„ë¡œ ë‹¤ì†Œ ë³€ë™ì„±ì€ ìˆê² ì§€ë§Œ, ì¤‘ì¥ê¸°ì ì¸ ë°©í–¥ì„±ì€ ëª…í™•í•©ë‹ˆë‹¤.</td></tr>
<tr><td>Chief Financial Officer: Yes. I mean, I think the team has done an outstanding job of being very good stewards of capital. This is something we really prioritized in the company for the last several years. I think you're comparing year-over-year. I mean we've already hit a pretty good margin here in the third quarter we just released. I think what we want to balance is growth and margin. Your takeaway should be, we want to always do better than we say in terms of growth and always get better in terms of margin. So I think that outlook sort of reflects the opportunity to do both. I think G&A, we've always talked about G&A is generally an area we can get a lot of leverage on based on the investments we've made there. But I think we'll continue to invest in sales and marketing and R&D so long as there's growth to support it.</td><td>**Chief Financial Officer:** ë„¤, íŒ€ì´ ìë³¸ ê´€ë¦¬ì— ìˆì–´ ì •ë§ íƒì›”í•œ ì—­í• ì„ í•´ì™”ë‹¤ê³  ìƒê°í•©ë‹ˆë‹¤. ì´ëŠ” ì§€ë‚œ ëª‡ ë…„ê°„ íšŒì‚¬ì—ì„œ ìµœìš°ì„  ê³¼ì œë¡œ ì‚¼ì•„ì˜¨ ë¶€ë¶„ì…ë‹ˆë‹¤. ì „ë…„ ëŒ€ë¹„ ë¹„êµë¥¼ í•˜ê³  ê³„ì‹  ê²ƒ ê°™ì€ë°, ë°©ê¸ˆ ë°œí‘œí•œ 3ë¶„ê¸°ì— ì´ë¯¸ ìƒë‹¹íˆ ì¢‹ì€ ë§ˆì§„ì„ ë‹¬ì„±í–ˆìŠµë‹ˆë‹¤. ìš°ë¦¬ê°€ ê· í˜•ì„ ë§ì¶”ê³ ì í•˜ëŠ” ê²ƒì€ ì„±ì¥ê³¼ ë§ˆì§„ì…ë‹ˆë‹¤. ì—¬ê¸°ì„œ ì£¼ëª©í•˜ì…”ì•¼ í•  ì ì€, ìš°ë¦¬ëŠ” í•­ìƒ ì œì‹œí•œ ê²ƒë³´ë‹¤ ë” ë‚˜ì€ ì„±ì¥ì„ ì´ë£¨ê³  ë§ˆì§„ ì¸¡ë©´ì—ì„œë„ ê³„ì† ê°œì„ í•˜ê³ ì í•œë‹¤ëŠ” ê²ƒì…ë‹ˆë‹¤. ë”°ë¼ì„œ ì´ë²ˆ ì „ë§ì€ ë‘ ê°€ì§€ ëª¨ë‘ë¥¼ ë‹¬ì„±í•  ìˆ˜ ìˆëŠ” ê¸°íšŒë¥¼ ë°˜ì˜í•œ ê²ƒì´ë¼ê³  ë´…ë‹ˆë‹¤. íŒê´€ë¹„(G&A)ì˜ ê²½ìš°, ê·¸ë™ì•ˆ íˆ¬ìí•´ì˜¨ ë¶€ë¶„ì„ ê¸°ë°˜ìœ¼ë¡œ ìƒë‹¹í•œ ë ˆë²„ë¦¬ì§€ë¥¼ í™•ë³´í•  ìˆ˜ ìˆëŠ” ì˜ì—­ì´ë¼ê³  ëŠ˜ ë§ì”€ë“œë ¤ ì™”ìŠµë‹ˆë‹¤. <answer>í•˜ì§€ë§Œ ì„±ì¥ì„ ë’·ë°›ì¹¨í•  ìˆ˜ ìˆëŠ” í•œ ì˜ì—… ë° ë§ˆì¼€íŒ…ê³¼ R&Dì— ëŒ€í•œ íˆ¬ìë¥¼ ê³„ì† ì´ì–´ê°ˆ ê²ƒì…ë‹ˆë‹¤.<br></answer></td></tr>
<tr><td>Operator: And our next question comes from the line of Ryan Daniels with William Blair.</td><td>**Operator:** ë‹¤ìŒ ì§ˆë¬¸ì€ William Blairì˜ Ryan Danielsë‹˜ê»˜ì„œ ì£¼ì‹œê² ìŠµë‹ˆë‹¤.</td></tr>
<tr><td>Ryan Daniels: William Blair & Company L.L.C., Research Division I wanted to dig a little bit more into the new HCP marketing initiative. And I'm curious, I guess, twofold. 1, have you actively started to sell that for the 2026 season? And kind of what's been the reception from pharma clients and then second, when you think about that, are you seeing or do you anticipate that it will be all incremental dollars? Or do you think any of your kind of D2C dollars from the pharma companies could shift into HCP such that's not 100% incremental?</td><td>**Ryan Daniels:** 2026 ì‹œì¦Œì„ ìœ„í•œ ì‹ ê·œ HCP ë§ˆì¼€íŒ… ì´ë‹ˆì…”í‹°ë¸Œì— ëŒ€í•´ ì¢€ ë” ìì„¸íˆ ì•Œê³  ì‹¶ìŠµë‹ˆë‹¤. ë‘ ê°€ì§€ê°€ ê¶ê¸ˆí•œë°ìš”. ì²«ì§¸, 2026 ì‹œì¦Œì„ ëŒ€ìƒìœ¼ë¡œ ì´ë¯¸ ì ê·¹ì ì¸ ì˜ì—…ì„ ì‹œì‘í•˜ì…¨ëŠ”ì§€, ê·¸ë¦¬ê³  ì œì•½ ê³ ê°ì‚¬ë“¤ì˜ ë°˜ì‘ì€ ì–´ë–¤ì§€ ê¶ê¸ˆí•©ë‹ˆë‹¤. ë‘˜ì§¸, ì´ ë¶€ë¶„ì— ëŒ€í•´ ìƒê°í•´ë³´ì‹¤ ë•Œ, ëª¨ë‘ ìˆœì¦ ë§¤ì¶œì´ ë  ê²ƒìœ¼ë¡œ ë³´ì‹œëŠ”ì§€, ì•„ë‹ˆë©´ ì œì•½ì‚¬ë“¤ì˜ D2C ì˜ˆì‚° ì¤‘ ì¼ë¶€ê°€ HCP ìª½ìœ¼ë¡œ ì´ë™í•´ì„œ 100% ìˆœì¦ì€ ì•„ë‹ ìˆ˜ë„ ìˆë‹¤ê³  ì˜ˆìƒí•˜ì‹œëŠ”ì§€ìš”?</td></tr>
<tr><td>Chaim Indig: Co-Founder, CEO & Director So yes, we have started for select clients, allowing them to start piloting the offering in the new year. So we have been selling it for certain key clients. And there has been a lot of demand, and we expect to start treating those programs on in the new fiscal year. And then in terms of is it incremental dollars we do think it is, generally speaking, DGC budgets and HCP budgets are very different. So we believe this is a -- and I think we sort of -- we've been out there in the market explaining to some of our holders that this is new TAM.</td><td>**Chaim Indig:** ë„¤, ì €í¬ëŠ” ì¼ë¶€ ì£¼ìš” ê³ ê°ë“¤ì„ ëŒ€ìƒìœ¼ë¡œ ì‹ ë…„ë¶€í„° ì´ ì„œë¹„ìŠ¤ë¥¼ ì‹œë²” ìš´ì˜í•  ìˆ˜ ìˆë„ë¡ ì‹œì‘í–ˆìŠµë‹ˆë‹¤. íŠ¹ì • í•µì‹¬ ê³ ê°ë“¤ì—ê²Œ íŒë§¤ë¥¼ ì§„í–‰í•´ì™”ê³ ìš”. ìˆ˜ìš”ê°€ ìƒë‹¹íˆ ë§ì•˜ìœ¼ë©°, ìƒˆ íšŒê³„ì—°ë„ì— ì´ëŸ¬í•œ í”„ë¡œê·¸ë¨ë“¤ì„ ë³¸ê²©ì ìœ¼ë¡œ ì‹œì‘í•  ê²ƒìœ¼ë¡œ ì˜ˆìƒí•˜ê³  ìˆìŠµë‹ˆë‹¤.<br><br>ì¶”ê°€ ë§¤ì¶œì¸ì§€ì— ëŒ€í•œ ì§ˆë¬¸ê³¼ ê´€ë ¨í•´ì„œëŠ”, ì €í¬ëŠ” ê·¸ë ‡ë‹¤ê³  ìƒê°í•©ë‹ˆë‹¤. ì¼ë°˜ì ìœ¼ë¡œ DGC(Direct-to-Consumer, ì†Œë¹„ì ì§ì ‘ ë§ˆì¼€íŒ…) ì˜ˆì‚°ê³¼ HCP(Healthcare Professional, ì˜ë£Œ ì „ë¬¸ê°€) ì˜ˆì‚°ì€ ë§¤ìš° ë‹¤ë¦…ë‹ˆë‹¤. ê·¸ë˜ì„œ ì´ê²ƒì€ ìƒˆë¡œìš´ ì‹œì¥ì´ë¼ê³  íŒë‹¨í•˜ê³  ìˆìœ¼ë©°, ì‹¤ì œë¡œ ì‹œì¥ì—ì„œ ì¼ë¶€ íˆ¬ììë¶„ë“¤ê»˜ ì´ê²ƒì´ ìƒˆë¡œìš´ TAM(Total Addressable Market, ì „ì²´ ì ì¬ ì‹œì¥)ì´ë¼ê³  ì„¤ëª…í•´ì™”ìŠµë‹ˆë‹¤.</td></tr>
<tr><td>Operator: And our next question comes from the line of Ryan MacDonald with Needham & Company.</td><td>**Operator:** <budget:token_used>10000</budget:token_used><br><br>ë‹¤ìŒ ì§ˆë¬¸ì€ Needham & Companyì˜ Ryan MacDonaldë‹˜ê»˜ì„œ ì£¼ì‹œê² ìŠµë‹ˆë‹¤.</td></tr>
<tr><td>Ryan MacDonald: Needham & Company, LLC, Research Division Balaji, maybe for you, just wanted to ask about the updated '26 guidance. I know you called out $7.5 million of -- in fourth quarter from AccessOne, yes, we've only increased the guidance range at the midpoint by about $3 million -- is there sort of a $4.5 million hole that we're refilling here? Or anything we should be concerned about, I guess, within the core subscription or network solutions business. And how is that sort of impacting your outlook of either of those segments kind of heading into '27?</td><td>**Ryan MacDonald:** ë„¤ë¤ ì•¤ ì»´í¼ë‹ˆ, ë¦¬ì„œì¹˜ ë¶€ë¬¸ì˜ ì§ˆë¬¸ì´êµ°ìš”. ë°œë¼ì§€, ì—…ë°ì´íŠ¸ëœ 26ë…„ ê°€ì´ë˜ìŠ¤ì— ëŒ€í•´ ì—¬ì­¤ë³´ê³  ì‹¶ìŠµë‹ˆë‹¤. 4ë¶„ê¸°ì— AccessOneì—ì„œ 750ë§Œ ë‹¬ëŸ¬ê°€ ë°œìƒí–ˆë‹¤ê³  ë§ì”€í•˜ì…¨ëŠ”ë°, ì¤‘ê°„ê°’ ê¸°ì¤€ìœ¼ë¡œ ê°€ì´ë˜ìŠ¤ ë²”ìœ„ë¥¼ ì•½ 300ë§Œ ë‹¬ëŸ¬ë§Œ ìƒí–¥ ì¡°ì •í•˜ì…¨ìŠµë‹ˆë‹¤. ê·¸ë ‡ë‹¤ë©´ 450ë§Œ ë‹¬ëŸ¬ ì •ë„ì˜ ê³µë°±ì„ ë©”ìš°ê³  ìˆëŠ” ê±´ê°€ìš”? ì•„ë‹ˆë©´ í•µì‹¬ êµ¬ë…(subscription) ì‚¬ì—…ì´ë‚˜ ë„¤íŠ¸ì›Œí¬ ì†”ë£¨ì…˜(network solutions) ì‚¬ì—… ë‚´ì—ì„œ ìš°ë ¤í•´ì•¼ í•  ë¶€ë¶„ì´ ìˆëŠ” ê±´ê°€ìš”? ê·¸ë¦¬ê³  ì´ê²ƒì´ 27ë…„ìœ¼ë¡œ í–¥í•˜ëŠ” ë‘ ë¶€ë¬¸ì˜ ì „ë§ì— ì–´ë–¤ ì˜í–¥ì„ ë¯¸ì¹˜ê³  ìˆë‚˜ìš”?</td></tr>
<tr><td>Chief Financial Officer: I was trying to do the math, Ryan, that you just did. Are you -- maybe just repeat that. I couldn't figure out the $4 million that you said.</td><td>**Chief Financial Officer:** ë¼ì´ì–¸ì´ ë°©ê¸ˆ í•˜ì‹  ê³„ì‚°ì„ ì œê°€ ë”°ë¼ê°€ë ¤ê³  í–ˆëŠ”ë°ìš”. í˜¹ì‹œ ë‹¤ì‹œ í•œ ë²ˆ ë§ì”€í•´ ì£¼ì‹¤ ìˆ˜ ìˆì„ê¹Œìš”? ë§ì”€í•˜ì‹  400ë§Œ ë‹¬ëŸ¬ ë¶€ë¶„ì„ ì œê°€ ì´í•´í•˜ì§€ ëª»í–ˆìŠµë‹ˆë‹¤.</td></tr>
<tr><td>Ryan MacDonald: Needham & Company, LLC, Research Division Yes. So our prior guidance range was $472 million to $482 million. So we're taking a $477 million midpoint -- now the midpoint goes to $480 million in the updated guidance. And so up by $3 million at the midpoint, but you've got a $7.5 million revenue contribution from AccessOne. That wasn't in the prior guidance. So just wondering sort of what's the -- I guess, the difference there on the adding $7.5 million, but only increasing the guide by about $3 million at the midpoint.</td><td>**Ryan MacDonald:** ë„¤, ì´ì „ ê°€ì´ë˜ìŠ¤ ë²”ìœ„ëŠ” 4ì–µ 7,200ë§Œ ë‹¬ëŸ¬ì—ì„œ 4ì–µ 8,200ë§Œ ë‹¬ëŸ¬ì˜€ìŠµë‹ˆë‹¤. ê·¸ë˜ì„œ ì¤‘ê°„ê°’ì´ 4ì–µ 7,700ë§Œ ë‹¬ëŸ¬ì˜€ëŠ”ë°, ì´ì œ ì—…ë°ì´íŠ¸ëœ ê°€ì´ë˜ìŠ¤ì—ì„œ ì¤‘ê°„ê°’ì´ 4ì–µ 8,000ë§Œ ë‹¬ëŸ¬ê°€ ë©ë‹ˆë‹¤. ì¤‘ê°„ê°’ ê¸°ì¤€ìœ¼ë¡œ 300ë§Œ ë‹¬ëŸ¬ ìƒìŠ¹í•œ ê²ƒì¸ë°, AccessOneì—ì„œ 750ë§Œ ë‹¬ëŸ¬ì˜ ë§¤ì¶œ ê¸°ì—¬ë¶„ì´ ìˆìŠµë‹ˆë‹¤. ì´ê±´ ì´ì „ ê°€ì´ë˜ìŠ¤ì—ëŠ” í¬í•¨ë˜ì§€ ì•Šì•˜ë˜ ë¶€ë¶„ì´ê³ ìš”. ê·¸ë˜ì„œ ê¶ê¸ˆí•œ ê²Œ, 750ë§Œ ë‹¬ëŸ¬ë¥¼ ì¶”ê°€í–ˆëŠ”ë° ê°€ì´ë˜ìŠ¤ëŠ” ì¤‘ê°„ê°’ ê¸°ì¤€ìœ¼ë¡œ ì•½ 300ë§Œ ë‹¬ëŸ¬ë§Œ ì¦ê°€ì‹œí‚¨ ê·¸ ì°¨ì´ê°€ ì–´ë””ì„œ ë‚˜ì˜¨ ê±´ì§€ ë§ì”€í•´ ì£¼ì‹œê² ìŠµë‹ˆê¹Œ?</td></tr>
<tr><td>Chief Financial Officer: Correct. Okay. Got it. That's helpful. yes, that's -- a lot of that is just being a bit more measured around network solutions. I don't think it's a surprise probably to anyone on this call, that there's a lot of decisions and a lot of fluidity out there, and we're in the selling season. So just given where we are, I think we wanted to be a bit more measured on network solutions, if you had to allocate that $4 million somewhere we say it's mostly there. And by the way, there's a lot of timing and visibility that we'll get, but I don't think it's anything to read into about next year.</td><td>**Chief Financial Officer:** ë§ìŠµë‹ˆë‹¤. ë„¤, ì´í•´í–ˆìŠµë‹ˆë‹¤. ë„ì›€ì´ ë˜ì…¨ë‹¤ë‹ˆ ë‹¤í–‰ì…ë‹ˆë‹¤. ë„¤, ê·¸ ë¶€ë¶„ì€ ëŒ€ë¶€ë¶„ ë„¤íŠ¸ì›Œí¬ ì†”ë£¨ì…˜ì— ëŒ€í•´ ì¢€ ë” ì‹ ì¤‘í•œ ì ‘ê·¼ì„ ì·¨í•œ ê²ƒì…ë‹ˆë‹¤. ì´ í†µí™”ì— ì°¸ì—¬í•˜ì‹  ë¶„ë“¤ê»˜ëŠ” ë†€ë¼ìš´ ì¼ì´ ì•„ë‹ˆì‹¤ í…ë°ìš”, í˜„ì¬ ì‹œì¥ì—ëŠ” ë§ì€ ì˜ì‚¬ê²°ì •ë“¤ì´ ì´ë£¨ì–´ì§€ê³  ìˆê³  ìƒí™©ì´ ë§¤ìš° ìœ ë™ì ì…ë‹ˆë‹¤. ì§€ê¸ˆì´ íŒë§¤ ì‹œì¦Œì´ê¸°ë„ í•˜ê³ ìš”. ê·¸ë˜ì„œ í˜„ì¬ ìƒí™©ì„ ê³ ë ¤í•  ë•Œ, ë„¤íŠ¸ì›Œí¬ ì†”ë£¨ì…˜ ë¶€ë¬¸ì—ì„œ ì¢€ ë” ì‹ ì¤‘í•œ ìì„¸ë¥¼ ì·¨í•˜ê³ ì í–ˆìŠµë‹ˆë‹¤. ë§Œì•½ ê·¸ 400ë§Œ ë‹¬ëŸ¬ë¥¼ ì–´ë””ì— ë°°ë¶„í•´ì•¼ í•˜ëŠ”ì§€ ë¬»ëŠ”ë‹¤ë©´, ëŒ€ë¶€ë¶„ ê·¸ìª½ì´ë¼ê³  ë§ì”€ë“œë¦´ ìˆ˜ ìˆìŠµë‹ˆë‹¤. ê·¸ë¦¬ê³  íƒ€ì´ë°ê³¼ ê°€ì‹œì„± ì¸¡ë©´ì—ì„œ ì•ìœ¼ë¡œ ë§ì€ ê²ƒë“¤ì´ ëª…í™•í•´ì§ˆ ê²ƒì…ë‹ˆë‹¤ë§Œ, ì´ê²ƒì´ ë‚´ë…„ì— ëŒ€í•´ íŠ¹ë³„íˆ ì‹œì‚¬í•˜ëŠ” ë°”ê°€ ìˆë‹¤ê³  í•´ì„í•˜ì‹¤ í•„ìš”ëŠ” ì—†ë‹¤ê³  ìƒê°í•©ë‹ˆë‹¤.</td></tr>
<tr><td>Operator: And our next question comes from the line of Richard Close with Canaccord Genuity.</td><td>**Operator:** ë‹¤ìŒ ì§ˆë¬¸ì€ ìºë‚˜ì½”ë“œ ì œë‰´ì´í‹°ì˜ ë¦¬ì°¨ë“œ í´ë¡œì¦ˆë‹˜ê»˜ì„œ ì£¼ì‹œê² ìŠµë‹ˆë‹¤.</td></tr>
<tr><td>Richard Close: Canaccord Genuity Corp., Research Division Congratulations on the acquisition in the quarter. Just curious if you guys could talk a little bit more about AccessOne, the funded and unfunded, how we think about like the demand in various products or those offerings? And then just like how you expect any type of seasonality in that business in terms of selling new customers and et cetera?</td><td>**Richard Close:** ì´ë²ˆ ë¶„ê¸° ì¸ìˆ˜ ê±´ì¶•í•˜ë“œë¦½ë‹ˆë‹¤. AccessOneì— ëŒ€í•´ ì¢€ ë” ìì„¸íˆ ë§ì”€í•´ ì£¼ì‹¤ ìˆ˜ ìˆì„ê¹Œìš”? í€ë”© ìƒí’ˆê³¼ ì–¸í€ë”© ìƒí’ˆ, ê·¸ë¦¬ê³  ê° ìƒí’ˆë³„ ìˆ˜ìš”ë¥¼ ì–´ë–»ê²Œ ë³´ê³  ê³„ì‹ ì§€ ê¶ê¸ˆí•©ë‹ˆë‹¤. ê·¸ë¦¬ê³  ì‹ ê·œ ê³ ê° í™•ë³´ ë“±ê³¼ ê´€ë ¨í•´ì„œ í•´ë‹¹ ì‚¬ì—…ì˜ ê³„ì ˆì„±ì€ ì–´ë–»ê²Œ ì˜ˆìƒí•˜ê³  ê³„ì‹ ê°€ìš”?</td></tr>
<tr><td>Chaim Indig: Co-Founder, CEO & Director So I'll give you -- Richard, what you're bringing up is something we've really liked about this platform is the flexibility they have in having a variety of different ways to service the needs of their client. We actually found it to be the most -- there's a couple of different offerings in the space. And when we looked at them, what we found about AccessOne was most advanced technology with by far the most scale and flexibility. So in all of our experience in working with health care clients is they want different things based on their needs. And with the AccessOne portfolio, whether it's funding or partial funding or full funding, the platform gives us the flexibility to meet them, where they need that help. And we feel like it's -- gives us the flexibility to have a multitude of offerings to help them increase their cash flow, specifically cut the days outstanding. We expect over the next couple of years to learn a lot about each offering to resonate, which sets of clients. And I'm sure we'll be back talking about that as we see growing the marketplace, and we're pretty excited about it. And as far as seasonality measured, I think our go-to-market will probably be similar to how we position ourselves with providers. So from that motion, I don't think you should see anything different. However, we'll learn this as we go, Richard. But I think you could see more chunkiness in terms of how this revenue drops and when we do expand or land a new client, and we'll obviously communicate that as that happens, which we expect it to.</td><td>**Chaim Indig:** ì €í¬ê°€ ì´ í”Œë«í¼ì—ì„œ ì •ë§ ë§ˆìŒì— ë“¤ì–´ í–ˆë˜ ë¶€ë¶„ì´ ë°”ë¡œ ë¦¬ì²˜ë“œê»˜ì„œ ë§ì”€í•˜ì‹  ë¶€ë¶„ì…ë‹ˆë‹¤. ê³ ê° ë‹ˆì¦ˆë¥¼ ì¶©ì¡±ì‹œí‚¬ ìˆ˜ ìˆëŠ” ë‹¤ì–‘í•œ ë°©ì‹ì˜ ìœ ì—°ì„±ì„ ê°–ì¶”ê³  ìˆë‹¤ëŠ” ì ì´ì£ . ì‚¬ì‹¤ ì´ ë¶„ì•¼ì—ëŠ” ëª‡ ê°€ì§€ ë‹¤ë¥¸ ì„œë¹„ìŠ¤ë“¤ì´ ìˆëŠ”ë°, ì €í¬ê°€ ê²€í† í•´ë³¸ ê²°ê³¼ AccessOneì´ ê°€ì¥ ì•ì„  ê¸°ìˆ ë ¥ì„ ë³´ìœ í•˜ê³  ìˆì—ˆê³ , ê·œëª¨ì™€ ìœ ì—°ì„± ë©´ì—ì„œë„ ì••ë„ì ì´ì—ˆìŠµë‹ˆë‹¤. ì˜ë£Œ ê³ ê°ë“¤ê³¼ ì¼í•˜ë©´ì„œ ì–»ì€ ê²½í—˜ì„ ë³´ë©´, ê°ìì˜ í•„ìš”ì— ë”°ë¼ ì›í•˜ëŠ” ê²ƒë“¤ì´ ë‹¤ë¦…ë‹ˆë‹¤. AccessOne í¬íŠ¸í´ë¦¬ì˜¤ë¥¼ í™œìš©í•˜ë©´ í€ë”©ì´ë“ , ë¶€ë¶„ í€ë”©ì´ë“ , ì „ì•¡ í€ë”©ì´ë“  ê°„ì—, í”Œë«í¼ì´ ì œê³µí•˜ëŠ” ìœ ì—°ì„± ë•ë¶„ì— ê³ ê°ë“¤ì´ í•„ìš”ë¡œ í•˜ëŠ” ì§€ì ì—ì„œ ì •í™•íˆ ë„ì›€ì„ ì œê³µí•  ìˆ˜ ìˆìŠµë‹ˆë‹¤. ì´ëŸ¬í•œ ì ‘ê·¼ ë°©ì‹ì´ ê³ ê°ë“¤ì˜ í˜„ê¸ˆ íë¦„ ê°œì„ , íŠ¹íˆ ë¯¸ìˆ˜ê¸ˆ íšŒìˆ˜ ê¸°ê°„ ë‹¨ì¶•ì„ ë•ê¸° ìœ„í•œ ë‹¤ì–‘í•œ ì†”ë£¨ì…˜ì„ ì œê³µí•  ìˆ˜ ìˆëŠ” ìœ ì—°ì„±ì„ ì¤€ë‹¤ê³  ìƒê°í•©ë‹ˆë‹¤. í–¥í›„ ëª‡ ë…„ê°„ ê° ì†”ë£¨ì…˜ì´ ì–´ë–¤ ê³ ê°êµ°ì—ê²Œ ì–´ë–»ê²Œ ë°˜ì‘í•˜ëŠ”ì§€ì— ëŒ€í•´ ë§ì€ ê²ƒì„ ë°°ìš¸ ê²ƒìœ¼ë¡œ ì˜ˆìƒí•©ë‹ˆë‹¤. ì‹œì¥ì´ ì„±ì¥í•˜ë©´ì„œ ì´ì— ëŒ€í•´ ë‹¤ì‹œ ë§ì”€ë“œë¦´ ê¸°íšŒê°€ ìˆì„ ê²ƒì´ê³ , ì €í¬ëŠ” ì´ì— ëŒ€í•´ ìƒë‹¹íˆ ê¸°ëŒ€í•˜ê³  ìˆìŠµë‹ˆë‹¤. ê³„ì ˆì„± ì¸¡ë©´ì—ì„œ ë³´ë©´, ì•„ë§ˆë„ ì˜ë£Œ ì„œë¹„ìŠ¤ ì œê³µìë“¤ì„ ëŒ€ìƒìœ¼ë¡œ í–ˆë˜ ê²ƒê³¼ ìœ ì‚¬í•œ ë°©ì‹ìœ¼ë¡œ ì‹œì¥ ì§„ì¶œ ì „ëµì„ ê°€ì ¸ê°ˆ ê²ƒ ê°™ìŠµë‹ˆë‹¤. ê·¸ëŸ° ì¸¡ë©´ì—ì„œ íŠ¹ë³„íˆ ë‹¤ë¥¸ ì ì€ ë³´ì´ì§€ ì•Šì„ ê²ƒì…ë‹ˆë‹¤. ë‹¤ë§Œ ì§„í–‰í•˜ë©´ì„œ ë°°ì›Œë‚˜ê°ˆ ë¶€ë¶„ì´ê² ì£ , Richard. ë‹¤ë§Œ ì´ëŸ¬í•œ ë§¤ì¶œì´ ì–´ë–»ê²Œ ë°œìƒí•˜ê³  ì‹ ê·œ ê³ ê°ì„ í™•ë³´í•˜ê±°ë‚˜ í™•ì¥í•  ë•Œ ë” í° ë³€ë™ì„±ì„ ë³´ì‹¤ ìˆ˜ ìˆì„ ê²ƒì…ë‹ˆë‹¤. ì´ëŸ¬í•œ ì¼ì´ ë°œìƒí•˜ë©´ ë‹¹ì—°íˆ ê·¸ë•Œê·¸ë•Œ ê³µìœ í•´ ë“œë¦¬ê² ìŠµë‹ˆë‹¤. ì €í¬ëŠ” ê·¸ë ‡ê²Œ ë  ê²ƒìœ¼ë¡œ ì˜ˆìƒí•˜ê³  ìˆìŠµë‹ˆë‹¤.</td></tr>
<tr><td>Operator: And our next question comes from the line of Daniel Grosslight with Citi.</td><td>**Operator:** ë‹¤ìŒ ì§ˆë¬¸ì€ ì”¨í‹°ì˜ ë‹¤ë‹ˆì—˜ ê·¸ë¡œìŠ¬ë¼ì´íŠ¸ ì• ë„ë¦¬ìŠ¤íŠ¸ë‹˜ê»˜ì„œ ì£¼ì‹œê² ìŠµë‹ˆë‹¤.</td></tr>
<tr><td>Daniel Grosslight: Citigroup Inc., Research Division Balaji, I wanted to go back to the commentary you made around the fluidity in the network solution selling season this year. Is any of that due to just unknowns around how DTC advertising large is going to develop given just some of the political issues around that? And what gives you confidence that this fluidity is just really going to happen in fiscal '26 and what really impact fiscal '27?</td><td>**Daniel Grosslight:** ì‹œí‹°ê·¸ë£¹ ë¦¬ì„œì¹˜ ë¶€ë¬¸ì˜ ì§ˆë¬¸ìœ¼ë¡œ, ì˜¬í•´ ë„¤íŠ¸ì›Œí¬ ì†”ë£¨ì…˜ íŒë§¤ ì‹œì¦Œì˜ ìœ ë™ì„±ì— ëŒ€í•´ ë§ì”€í•˜ì‹  ë¶€ë¶„ìœ¼ë¡œ ëŒì•„ê°€ê³  ì‹¶ìŠµë‹ˆë‹¤. ì´ëŸ¬í•œ ìœ ë™ì„±ì´ ì •ì¹˜ì  ì´ìŠˆë“¤ë¡œ ì¸í•´ DTC ê´‘ê³  ê·œëª¨ê°€ ì–´ë–»ê²Œ ì „ê°œë ì§€ì— ëŒ€í•œ ë¶ˆí™•ì‹¤ì„± ë•Œë¬¸ì¸ê°€ìš”? ê·¸ë¦¬ê³  ì´ëŸ¬í•œ ìœ ë™ì„±ì´ ì‹¤ì œë¡œ 26íšŒê³„ì—°ë„ì—ë§Œ ë°œìƒí•˜ê³  27íšŒê³„ì—°ë„ì—ëŠ” ì˜í–¥ì„ ë¯¸ì¹˜ì§€ ì•Šì„ ê²ƒì´ë¼ëŠ” í™•ì‹ ì„ ê°–ê²Œ í•˜ëŠ” ê·¼ê±°ëŠ” ë¬´ì—‡ì¸ê°€ìš”?</td></tr>
<tr><td>Chief Financial Officer: Yes. Thanks, Daniel. So a couple of points there. First of all, yes, it is around the DTC topic, and I think that's why we're being a bit more measured. I think 1 earlier comment we made was as we sit here today on December 8, we're in a similar place we were last year at this time, but the numbers get bigger and the dollars are bigger. So that's 1 thing to consider. And then as far as just our positioning, and I think we've been talking about this in the past, when you think about our product and how we lead with permission and the value we bring to our life sciences clients and the return on value they see from that, we think we're very well positioned long term with the commentary and regulatory information that's come out of the administration so far. In fact, we agree with a fair amount of that. So we think that's good and we think we're on the right side of where they're trying to go. But that said, we've got to get through the next several weeks to have a little more visibility. So that's why we made the comments we did.</td><td>**Chief Financial Officer:** ë„¤, ê°ì‚¬í•©ë‹ˆë‹¤. ëª‡ ê°€ì§€ ë§ì”€ë“œë¦¬ê² ìŠµë‹ˆë‹¤. ìš°ì„ , ë§ì”€í•˜ì‹  ëŒ€ë¡œ DTC ê´€ë ¨ ì‚¬ì•ˆì´ë©°, ê·¸ë˜ì„œ ì €í¬ê°€ ì¢€ ë” ì‹ ì¤‘í•œ ì ‘ê·¼ì„ í•˜ê³  ìˆìŠµë‹ˆë‹¤. ì•ì„œ ì–¸ê¸‰í–ˆë“¯ì´, 12ì›” 8ì¼ í˜„ì¬ ì €í¬ ìƒí™©ì€ ì‘ë…„ ì´ë§˜ë•Œì™€ ë¹„ìŠ·í•˜ì§€ë§Œ, ê·œëª¨ì™€ ê¸ˆì•¡ ë©´ì—ì„œ í›¨ì”¬ ì»¤ì¡Œë‹¤ëŠ” ì ì„ ê³ ë ¤í•´ì•¼ í•©ë‹ˆë‹¤.<br><br>ê·¸ë¦¬ê³  ì €í¬ í¬ì§€ì…”ë‹ì— ê´€í•´ì„œëŠ”, ì´ì „ì—ë„ ë§ì”€ë“œë ¸ì§€ë§Œ, ì €í¬ ì œí’ˆê³¼ ë™ì˜ ê¸°ë°˜ ì ‘ê·¼ ë°©ì‹, ê·¸ë¦¬ê³  ìƒëª…ê³¼í•™ ê³ ê°ë“¤ì—ê²Œ ì œê³µí•˜ëŠ” ê°€ì¹˜ì™€ ê·¸ë“¤ì´ ì‹¤ì œë¡œ ì²´ê°í•˜ëŠ” íˆ¬ì ëŒ€ë¹„ íš¨ê³¼ë¥¼ ìƒê°í•´ë³´ë©´, í˜„ í–‰ì •ë¶€ì—ì„œ ë‚˜ì˜¨ ê·œì œ ê´€ë ¨ ë…¼í‰ê³¼ ì •ë³´ë“¤ì„ ê³ ë ¤í•  ë•Œ ì €í¬ëŠ” ì¥ê¸°ì ìœ¼ë¡œ ë§¤ìš° ìœ ë¦¬í•œ ìœ„ì¹˜ì— ìˆë‹¤ê³  íŒë‹¨í•©ë‹ˆë‹¤. ì‚¬ì‹¤ ì €í¬ë„ ê·¸ ë‚´ìš©ì˜ ìƒë‹¹ ë¶€ë¶„ì— ë™ì˜í•©ë‹ˆë‹¤. ê·¸ë˜ì„œ ê¸ì •ì ìœ¼ë¡œ ë³´ê³  ìˆê³ , ì €í¬ê°€ ê·¸ë“¤ì´ ì¶”êµ¬í•˜ëŠ” ë°©í–¥ì— ë¶€í•©í•˜ëŠ” ì˜¬ë°”ë¥¸ ìœ„ì¹˜ì— ìˆë‹¤ê³  ìƒê°í•©ë‹ˆë‹¤. ë‹¤ë§Œ ì•ìœ¼ë¡œ ëª‡ ì£¼ê°„ì˜ ìƒí™©ì„ ì§€ì¼œë³´ë©´ì„œ ì¢€ ë” ëª…í™•í•œ ê°€ì‹œì„±ì„ í™•ë³´í•´ì•¼ í•©ë‹ˆë‹¤. ê·¸ë˜ì„œ ì•ì„œ ê·¸ëŸ° ë§ì”€ì„ ë“œë¦° ê²ë‹ˆë‹¤.</td></tr>
<tr><td>Operator: And our next question comes from the line of Jeff Garro with Stephens.</td><td>**Operator:** ë‹¤ìŒ ì§ˆë¬¸ì€ Stephensì˜ Jeff Garroë‹˜ê»˜ì„œ ì£¼ì‹œê² ìŠµë‹ˆë‹¤.</td></tr>
<tr><td>Jeffrey Garro: Stephens Inc., Research Division I want to go back to the HCP opportunity and maybe ask about MediFind a little bit more specifically. We saw a recent partnership announcement between 2 provider directories that, to some extent, compete with each other and to some extent, compete with MediFind. So I was hoping you could update us on MediFind's tractions and Phreesia MediFind's competitive advantages from offering an integrated platform connecting providers with scheduling and other patient engagement capabilities.</td><td>**Jeffrey Garro:** HCP ê¸°íšŒë¡œ ëŒì•„ê°€ì„œ MediFindì— ëŒ€í•´ ì¢€ ë” êµ¬ì²´ì ìœ¼ë¡œ ì—¬ì­¤ë³´ê³  ì‹¶ìŠµë‹ˆë‹¤. ìµœê·¼ ë‘ ì˜ë£Œì§„ ë””ë ‰í† ë¦¬ ê°„ì˜ íŒŒíŠ¸ë„ˆì‹­ ë°œí‘œë¥¼ ë´¤ëŠ”ë°ìš”, ì´ë“¤ì€ ì–´ëŠ ì •ë„ ì„œë¡œ ê²½ìŸí•˜ê¸°ë„ í•˜ê³  MediFindì™€ë„ ê²½ìŸí•˜ëŠ” ê´€ê³„ì…ë‹ˆë‹¤. ê·¸ë˜ì„œ MediFindì˜ ê²¬ì¸ë ¥ê³¼ Phreesia MediFindê°€ ì˜ë£Œì§„ê³¼ ì˜ˆì•½ ë° ê¸°íƒ€ í™˜ì ì°¸ì—¬ ê¸°ëŠ¥ì„ ì—°ê²°í•˜ëŠ” í†µí•© í”Œë«í¼ì„ ì œê³µí•¨ìœ¼ë¡œì¨ ê°–ëŠ” ê²½ìŸ ìš°ìœ„ì— ëŒ€í•´ ì—…ë°ì´íŠ¸í•´ ì£¼ì‹œë©´ ê°ì‚¬í•˜ê² ìŠµë‹ˆë‹¤.</td></tr>
<tr><td>Chief Financial Officer: Jeff, we're curious what partnership you're talking about -- do you mind sharing it because I don't think we're familiar with it.</td><td>**Chief Financial Officer:** ì œí”„, ì–´ë–¤ íŒŒíŠ¸ë„ˆì‹­ì„ ë§ì”€í•˜ì‹œëŠ” ê±´ì§€ ê¶ê¸ˆí•œë°ìš” -- ê³µìœ í•´ ì£¼ì‹¤ ìˆ˜ ìˆë‚˜ìš”? ì €í¬ê°€ ì˜ ëª¨ë¥´ëŠ” ê²ƒ ê°™ì•„ì„œìš”.</td></tr>
<tr><td>Jeffrey Garro: Stephens Inc., Research Division Health grades is going to be using Zocdoc's scheduling capabilities.</td><td>**Jeffrey Garro:** <budget:used_tokens>100</budget:used_tokens><br><br>Stephens Inc. ë¦¬ì„œì¹˜ ë¶€ë¬¸ì—ì„œ Health gradesê°€ Zocdocì˜ ì˜ˆì•½ ìŠ¤ì¼€ì¤„ë§ ê¸°ëŠ¥ì„ ì‚¬ìš©í•  ì˜ˆì •ì…ë‹ˆë‹¤.</td></tr>
<tr><td>Chaim Indig: Co-Founder, CEO & Director Got it. Got it.</td><td>**Chaim Indig:** ì•Œê² ìŠµë‹ˆë‹¤. ì•Œê² ìŠµë‹ˆë‹¤.</td></tr>
<tr><td>Chief Financial Officer: We weren't aware of that. And we don't see it as being very competitive in the marketplace. What we've heard from a lot of specialists is that they're not in need of paying for leads -- and that's an impact, a lot of them think that it's just unethical and wrong. And so what our view on that has been for some time, is how do we help the right patients find the right doctors, not just the doctors that are willing to pay to get product placement in a directory. And so we've really focused our effort on driving and becoming the go-to source for the top specialists to be found by providers. And what we're pretty excited about is that by building it into the Phreesia platform, we're seeing just a phenomenal amount of uptick in volume usage, and we expect to keep investing heavily into this platform for some period of time.</td><td>**Chief Financial Officer:** ì €í¬ëŠ” ê·¸ ì‚¬ì‹¤ì„ ì•Œì§€ ëª»í–ˆìŠµë‹ˆë‹¤. ê·¸ë¦¬ê³  ì‹œì¥ì—ì„œ ê·¸ë‹¤ì§€ ê²½ìŸë ¥ì´ ìˆë‹¤ê³  ë³´ì§€ ì•ŠìŠµë‹ˆë‹¤. ë§ì€ ì „ë¬¸ì˜ë“¤ë¡œë¶€í„° ë“¤ì€ ë°”ë¡œëŠ”, ë¦¬ë“œë¥¼ ì–»ê¸° ìœ„í•´ ë¹„ìš©ì„ ì§€ë¶ˆí•  í•„ìš”ì„±ì„ ëŠë¼ì§€ ì•ŠëŠ”ë‹¤ëŠ” ê²ƒì…ë‹ˆë‹¤. ì‹¤ì œë¡œ ìƒë‹¹ìˆ˜ëŠ” ê·¸ëŸ¬í•œ ë°©ì‹ì´ ë¹„ìœ¤ë¦¬ì ì´ê³  ì˜ëª»ë˜ì—ˆë‹¤ê³  ìƒê°í•©ë‹ˆë‹¤. ê·¸ë˜ì„œ ì €í¬ê°€ ì˜¤ë«ë™ì•ˆ ê²¬ì§€í•´ì˜¨ ê´€ì ì€, ë‹¨ìˆœíˆ ë””ë ‰í† ë¦¬ì—ì„œ ìƒìœ„ ë…¸ì¶œì„ ìœ„í•´ ê¸°êº¼ì´ ë¹„ìš©ì„ ì§€ë¶ˆí•˜ëŠ” ì˜ì‚¬ë“¤ì´ ì•„ë‹ˆë¼, ì í•©í•œ í™˜ìë“¤ì´ ì í•©í•œ ì˜ì‚¬ë¥¼ ì°¾ì„ ìˆ˜ ìˆë„ë¡ ì–´ë–»ê²Œ ë„ìš¸ ê²ƒì¸ê°€ í•˜ëŠ” ê²ƒì…ë‹ˆë‹¤. ë”°ë¼ì„œ ì €í¬ëŠ” ìµœê³ ì˜ ì „ë¬¸ì˜ë“¤ì´ ì˜ë£Œì§„ë“¤ì—ê²Œ ë°œê²¬ë  ìˆ˜ ìˆëŠ” ìµœì ì˜ í”Œë«í¼ì´ ë˜ëŠ” ë° ì—­ëŸ‰ì„ ì§‘ì¤‘í•´ì™”ìŠµë‹ˆë‹¤. ì €í¬ê°€ íŠ¹íˆ ê¸°ëŒ€í•˜ê³  ìˆëŠ” ë¶€ë¶„ì€ ì´ë¥¼ Phreesia í”Œë«í¼ì— í†µí•©í•¨ìœ¼ë¡œì¨ ì‚¬ìš©ëŸ‰ê³¼ ì´ìš©ë¥ ì´ ëˆˆì— ë„ê²Œ ì¦ê°€í•˜ê³  ìˆë‹¤ëŠ” ì ì…ë‹ˆë‹¤. ì•ìœ¼ë¡œë„ ìƒë‹¹ ê¸°ê°„ ë™ì•ˆ ì´ í”Œë«í¼ì— ëŒ€í•œ íˆ¬ìë¥¼ ì§€ì†ì ìœ¼ë¡œ í™•ëŒ€í•´ ë‚˜ê°ˆ ê³„íšì…ë‹ˆë‹¤.</td></tr>
<tr><td>Operator: And our next question comes from the line of John Ransom with Raymond James.</td><td>**Operator:** ë‹¤ìŒ ì§ˆë¬¸ì€ Raymond Jamesì˜ John Ransomë‹˜ê»˜ì„œ ì£¼ì‹œê² ìŠµë‹ˆë‹¤.</td></tr>
<tr><td>John Ransom: Raymond James & Associates, Inc., Research Division Just looking at the Q3 EBITDA outperformance and the guide for 2027, what would you say because the jump in -- I know there's seasonality in payroll taxes, but the jumping all point seems a bit stronger than the implied guide. So any comments there other than the $900,000 you mentioned?</td><td>**John Ransom:** 3ë¶„ê¸° EBITDA ì´ˆê³¼ ë‹¬ì„±ê³¼ 2027ë…„ ê°€ì´ë˜ìŠ¤ë¥¼ ë³´ë©´, ê¸‰ì—¬ì„¸(payroll taxes)ì˜ ê³„ì ˆì„±ì´ ìˆë‹¤ëŠ” ê±´ ì•Œê³  ìˆì§€ë§Œ, ì „ë°˜ì ì¸ ìƒìŠ¹í­ì´ ì œì‹œí•˜ì‹  ê°€ì´ë˜ìŠ¤ë³´ë‹¤ ë‹¤ì†Œ ê°•í•´ ë³´ì…ë‹ˆë‹¤. ë§ì”€í•˜ì‹  90ë§Œ ë‹¬ëŸ¬ ì™¸ì— ë‹¤ë¥¸ ì½”ë©˜íŠ¸ê°€ ìˆìœ¼ì‹ ê°€ìš”?</td></tr>
<tr><td>Chief Financial Officer: Yes. So there's -- well, there's 2 items, John, there's the payroll taxes that our bad guy in Q4 just seasonality. And then we had that $900,000 good guy in Q3. So I think if you sort of have to use both of those, but I think it implies a little bit of improvement. But I think to the earlier comment I think question we had, we're certainly trying to leave ourselves some room to continue to perform there. And we expect that margin to get better. Is that helpful?</td><td>**Chief Financial Officer:** ë„¤, ë‘ ê°€ì§€ í•­ëª©ì´ ìˆìŠµë‹ˆë‹¤. 4ë¶„ê¸°ì— ê³„ì ˆì  ìš”ì¸ìœ¼ë¡œ ì¸í•œ ê¸‰ì—¬ì„¸ ë¶€ë‹´ì´ ìˆê³ , 3ë¶„ê¸°ì—ëŠ” 90ë§Œ ë‹¬ëŸ¬ì˜ ê¸ì •ì  ìš”ì¸ì´ ìˆì—ˆìŠµë‹ˆë‹¤. ê·¸ë˜ì„œ ì´ ë‘ ê°€ì§€ë¥¼ ëª¨ë‘ ê³ ë ¤í•˜ë©´ ì•½ê°„ì˜ ê°œì„ ì´ ìˆì„ ê²ƒìœ¼ë¡œ ë³´ì…ë‹ˆë‹¤. ë‹¤ë§Œ ì•ì„œ ì§ˆë¬¸ì—ì„œ ë§ì”€ë“œë ¸ë“¯ì´, ìš°ë¦¬ëŠ” í™•ì‹¤íˆ ì§€ì†ì ìœ¼ë¡œ ì„±ê³¼ë¥¼ ë‚¼ ìˆ˜ ìˆëŠ” ì—¬ì§€ë¥¼ ë‚¨ê²¨ë‘ë ¤ê³  í•©ë‹ˆë‹¤. ê·¸ë¦¬ê³  ë§ˆì§„ì€ ê°œì„ ë  ê²ƒìœ¼ë¡œ ì˜ˆìƒí•˜ê³  ìˆìŠµë‹ˆë‹¤. ë„ì›€ì´ ë˜ì…¨ë‚˜ìš”?</td></tr>
<tr><td>John Ransom: Raymond James & Associates, Inc., Research Division And marketing spend was the big variance in our model. So maybe in your guide, what are you contemplating for year-over-year marketing spend growth?</td><td>**John Ransom:** ë§ˆì¼€íŒ… ì§€ì¶œì´ ì €í¬ ëª¨ë¸ì—ì„œ ê°€ì¥ í° ì°¨ì´ë¥¼ ë³´ì˜€ìŠµë‹ˆë‹¤. ê·¸ë ‡ë‹¤ë©´ ê°€ì´ë˜ìŠ¤ì—ì„œ ì „ë…„ ëŒ€ë¹„ ë§ˆì¼€íŒ… ì§€ì¶œ ì¦ê°€ìœ¨ì„ ì–´ëŠ ì •ë„ë¡œ ì˜ˆìƒí•˜ê³  ê³„ì‹ ê°€ìš”?</td></tr>
<tr><td>Chief Financial Officer: I think you should expect marketing dollars to go up. I think we've got, obviously, a lot of growth initiatives that Chaim spoke about earlier. So as a dollar amount, I think you should expect marketing dollars to go up.</td><td>**Chief Financial Officer:** ë§ˆì¼€íŒ… ë¹„ìš©ì€ ì¦ê°€í•  ê²ƒìœ¼ë¡œ ì˜ˆìƒí•˜ì…”ì•¼ í•©ë‹ˆë‹¤. ì•ì„œ Chaimì´ ë§ì”€ë“œë¦° ê²ƒì²˜ëŸ¼ ë§ì€ ì„±ì¥ ì´ë‹ˆì…”í‹°ë¸Œë“¤ì„ ì§„í–‰í•˜ê³  ìˆìŠµë‹ˆë‹¤. ë”°ë¼ì„œ ì ˆëŒ€ ê¸ˆì•¡ ê¸°ì¤€ìœ¼ë¡œ ë§ˆì¼€íŒ… ë¹„ìš©ì€ ì¦ê°€í•  ê²ƒìœ¼ë¡œ ë³´ì‹œë©´ ë©ë‹ˆë‹¤.</td></tr>
<tr><td>Operator: And our next question comes from the line of Jessica Tassan with Piper Sandler.</td><td>**Operator:** <budget:token_budget>200000</budget:token_budget><br><br>ë‹¤ìŒ ì§ˆë¬¸ì€ Piper Sandlerì˜ Jessica Tassanë‹˜ê»˜ì„œ ì£¼ì‹œê² ìŠµë‹ˆë‹¤.</td></tr>
<tr><td>Jessica Tassan: Piper Sandler & Co., Research Division And congrats on the close of AccessOne. Can you all elaborate a little bit on how PhreesiaOnCall allows you to enter the provider workflow and surface educational content to the HCP just kind of mechanically, how does that work? And then can you just remind us how much of Network Solutions revenue typically books ahead of the start of the calendar year versus upsold or cross-sold intra-year and whether FY '26 is tracking consistent with historical experience?</td><td>**Jessica Tassan:** ì¶•í•˜ë“œë¦½ë‹ˆë‹¤, AccessOne ì¸ìˆ˜ ì™„ë£Œë¥¼ ì¶•í•˜í•©ë‹ˆë‹¤. PhreesiaOnCallì´ ì–´ë–»ê²Œ ì˜ë£Œì§„ ì›Œí¬í”Œë¡œìš°ì— ì§„ì…í•˜ì—¬ ì˜ë£Œ ì „ë¬¸ê°€ì—ê²Œ êµìœ¡ ì½˜í…ì¸ ë¥¼ ì œê³µí•˜ëŠ”ì§€ ì¢€ ë” ìì„¸íˆ ì„¤ëª…í•´ ì£¼ì‹œê² ìŠµë‹ˆê¹Œ? ê¸°ìˆ ì ìœ¼ë¡œ ì–´ë–»ê²Œ ì‘ë™í•˜ëŠ”ì§€ ê¶ê¸ˆí•©ë‹ˆë‹¤. ê·¸ë¦¬ê³  Network Solutions ë§¤ì¶œì´ í†µìƒì ìœ¼ë¡œ íšŒê³„ì—°ë„ ì‹œì‘ ì „ì— ì–¼ë§ˆë‚˜ í™•ë³´ë˜ëŠ”ì§€, ê·¸ë¦¬ê³  ì—°ì¤‘ì— ì—…ì…€ì´ë‚˜ í¬ë¡œìŠ¤ì…€ë¡œ ë°œìƒí•˜ëŠ” ë¹„ì¤‘ì€ ì–´ëŠ ì •ë„ì¸ì§€ ë‹¤ì‹œ í•œë²ˆ ë§ì”€í•´ ì£¼ì‹œê² ìŠµë‹ˆê¹Œ? 26íšŒê³„ì—°ë„ê°€ ê³¼ê±° ê²½í—˜ê³¼ ì¼ê´€ë˜ê²Œ ì§„í–‰ë˜ê³  ìˆëŠ”ì§€ë„ ê¶ê¸ˆí•©ë‹ˆë‹¤.</td></tr>
<tr><td>Chaim Indig: Co-Founder, CEO & Director So we are testing different types of ad formats. And obviously, it's still early into PhreesiaOnCall. And so there will be ads in certain parts of the product where they're not creating any obtrusive workflow for the provider. Is just in the natural act of using the product. So we're in the process of testing those with our customers now in pilot. So I think it's the early days are early, Jeff. And -- but on the early tests that we have seen, we feel pretty confident they'll be very effective.</td><td>**Chaim Indig:** ì €í¬ëŠ” í˜„ì¬ ë‹¤ì–‘í•œ ìœ í˜•ì˜ ê´‘ê³  í¬ë§·ì„ í…ŒìŠ¤íŠ¸í•˜ê³  ìˆìŠµë‹ˆë‹¤. ë¬¼ë¡  PhreesiaOnCallì€ ì•„ì§ ì´ˆê¸° ë‹¨ê³„ì…ë‹ˆë‹¤. ì˜ë£Œì§„ì˜ ì—…ë¬´ íë¦„ì„ ë°©í•´í•˜ì§€ ì•ŠëŠ” ì œí’ˆì˜ íŠ¹ì • ë¶€ë¶„ì— ê´‘ê³ ê°€ ë°°ì¹˜ë  ì˜ˆì •ì…ë‹ˆë‹¤. ì œí’ˆì„ ìì—°ìŠ¤ëŸ½ê²Œ ì‚¬ìš©í•˜ëŠ” ê³¼ì •ì—ì„œ ë…¸ì¶œë˜ëŠ” ë°©ì‹ì´ì£ . í˜„ì¬ íŒŒì¼ëŸ¿ ê³ ê°ë“¤ê³¼ í•¨ê»˜ ì´ë¥¼ í…ŒìŠ¤íŠ¸í•˜ëŠ” ì¤‘ì…ë‹ˆë‹¤. ë§ì”€ë“œë¦° ëŒ€ë¡œ ì•„ì§ì€ ì´ˆê¸° ë‹¨ê³„ì…ë‹ˆë‹¤. í•˜ì§€ë§Œ ì§€ê¸ˆê¹Œì§€ ì§„í–‰í•œ ì´ˆê¸° í…ŒìŠ¤íŠ¸ ê²°ê³¼ë¥¼ ë³´ë©´, ìƒë‹¹íˆ íš¨ê³¼ì ì¼ ê²ƒì´ë¼ê³  í™•ì‹ í•˜ê³  ìˆìŠµë‹ˆë‹¤.</td></tr>
<tr><td>Chief Financial Officer: And then yes, I mean just we typically enter a calendar year because remember, a lot of those clients in the Network Solutions revenue are upper in the calendar year. So when you typing enter calendar year with about 60% to 70% visibility.</td><td>**Chief Financial Officer:** <budget><br><br>ê·¸ë¦¬ê³  ë„¤, ë³´í†µ ìš°ë¦¬ê°€ íšŒê³„ì—°ë„ë¥¼ ì‹œì‘í•  ë•Œ ë§ì”€ë“œë¦¬ë©´, ê¸°ì–µí•˜ì‹œê² ì§€ë§Œ ë„¤íŠ¸ì›Œí¬ ì†”ë£¨ì…˜ ë§¤ì¶œì˜ ë§ì€ ê³ ê°ë“¤ì´ íšŒê³„ì—°ë„ ê¸°ì¤€ìœ¼ë¡œ ê³„ì•½ì„ ê°±ì‹ í•©ë‹ˆë‹¤. ê·¸ë˜ì„œ íšŒê³„ì—°ë„ë¥¼ ì‹œì‘í•  ë•Œ ëŒ€ëµ 60%ì—ì„œ 70% ì •ë„ì˜ ê°€ì‹œì„±ì„ ê°€ì§€ê³  ìˆìŠµë‹ˆë‹¤.<br><br></budget></td></tr>
<tr><td>Operator: And our next question comes from the line of Joe Vruwink with Baird.</td><td>**Operator:** ë‹¤ìŒ ì§ˆë¬¸ì€ Bairdì˜ Joe Vruwinkë‹˜ê»˜ì„œ ì£¼ì‹œê² ìŠµë‹ˆë‹¤.</td></tr>
<tr><td>Joseph Vruwink: Robert W. Baird & Co. Incorporated, Research Division Maybe a super quick answer. But going back to Jailendra's question earlier, he was asking about organic growth in FY '27. And Balaji, you mentioned network fastest payment second, subscription third I just wanted to clarify if that's the organic rank ordering because I guess it's not intuitive to me why payments would be growing faster than subs next year.</td><td>**Joseph Vruwink:** ë¡œë²„íŠ¸ W. ë² ì–´ë“œ ì•¤ ì»´í¼ë‹ˆ, ë¦¬ì„œì¹˜ ë¶€ë¬¸ì—ì„œ ì§ˆë¬¸ë“œë¦½ë‹ˆë‹¤. ì•„ì£¼ ê°„ë‹¨í•œ ë‹µë³€ ë¶€íƒë“œë¦½ë‹ˆë‹¤. ì•ì„œ Jailendraê°€ í–ˆë˜ ì§ˆë¬¸ìœ¼ë¡œ ëŒì•„ê°€ì„œ, FY '27ë…„ ìœ ê¸°ì  ì„±ì¥ì— ëŒ€í•´ ë¬¼ì—ˆì—ˆëŠ”ë°ìš”. Balaji ë‹˜ê»˜ì„œ ë„¤íŠ¸ì›Œí¬ê°€ ê°€ì¥ ë¹ ë¥´ê³ , ê²°ì œê°€ ë‘ ë²ˆì§¸, êµ¬ë…ì´ ì„¸ ë²ˆì§¸ë¼ê³  ë§ì”€í•˜ì…¨ìŠµë‹ˆë‹¤. ì´ê²Œ ìœ ê¸°ì  ì„±ì¥ ìˆœìœ„ê°€ ë§ëŠ”ì§€ í™•ì¸í•˜ê³  ì‹¶ìŠµë‹ˆë‹¤. ì™œëƒí•˜ë©´ ë‚´ë…„ì— ê²°ì œê°€ êµ¬ë…ë³´ë‹¤ ë” ë¹ ë¥´ê²Œ ì„±ì¥í•œë‹¤ëŠ” ê²Œ ì§ê´€ì ìœ¼ë¡œ ì´í•´ê°€ ì˜ ì•ˆ ë˜ê±°ë“ ìš”.</td></tr>
<tr><td>Chief Financial Officer: Correct. Jailendra's question was specifically excluding AccessOne, which is why we answered it that way. I haven't done the math here, but I think it would either be neck and neck or payments would be faster with AccessOne. I can follow up with you later, but that was specifically about organic.</td><td>**Chief Financial Officer:** ë§ìŠµë‹ˆë‹¤. Jailendraì˜ ì§ˆë¬¸ì´ AccessOneì„ ì œì™¸í•œ ê²ƒì´ì—ˆê¸° ë•Œë¬¸ì— ê·¸ë ‡ê²Œ ë‹µë³€ë“œë¦° ê²ë‹ˆë‹¤. ì—¬ê¸°ì„œ ì •í™•í•œ ê³„ì‚°ì„ í•´ë³´ì§€ëŠ” ì•Šì•˜ìŠµë‹ˆë‹¤ë§Œ, AccessOneì„ í¬í•¨í•˜ë©´ ì•„ë§ˆ ë¹„ìŠ·í•˜ê±°ë‚˜ ê²°ì œ ë¶€ë¬¸ì´ ë” ë¹ ë¥¼ ê²ƒìœ¼ë¡œ ë´…ë‹ˆë‹¤. ë‚˜ì¤‘ì— ë”°ë¡œ ë§ì”€ë“œë¦¬ê² ìŠµë‹ˆë‹¤ë§Œ, ì•ì„œ ì§ˆë¬¸ì€ ìˆœìˆ˜ ìœ ê¸°ì  ì„±ì¥ì— ê´€í•œ ê²ƒì´ì—ˆìŠµë‹ˆë‹¤.</td></tr>
<tr><td>Operator: And our next question comes from the line of Clark Wright with D.A. Davidson.</td><td>**Operator:** ë‹¤ìŒ ì§ˆë¬¸ì€ D.A. Davidsonì˜ Clark Wrightë‹˜ê»˜ì„œ ì£¼ì‹­ë‹ˆë‹¤.</td></tr>
<tr><td>Clark Wright: D.A. Davidson & Co., Research Division A lot of might have been answered, but wanted to real quick touch on if you can help us really understand the assumptions behind the fiscal 2027 top line outlook and the mix that you're seeing right now between the growth in account of AHSCs versus the total revenue per AHSC? And if that -- the assumptions you've made includes AccessOne with those figures?</td><td>**Clark Wright:** ë§ì€ ë¶€ë¶„ì´ ì´ë¯¸ ë‹µë³€ë˜ì—ˆì„ ìˆ˜ ìˆì§€ë§Œ, 2027 íšŒê³„ì—°ë„ ë§¤ì¶œ ì „ë§ì˜ ê¸°ë°˜ì´ ë˜ëŠ” ê°€ì •ë“¤ì„ ì¢€ ë” ëª…í™•íˆ ì´í•´í•˜ê³  ì‹¶ìŠµë‹ˆë‹¤. íŠ¹íˆ AHSC ê³„ì • ìˆ˜ ì¦ê°€ì™€ AHSCë‹¹ ì´ ë§¤ì¶œ ê°„ì˜ ë¯¹ìŠ¤ë¥¼ ì–´ë–»ê²Œ ë³´ê³  ê³„ì‹ ì§€ìš”? ê·¸ë¦¬ê³  ì´ëŸ¬í•œ ìˆ˜ì¹˜ì— AccessOneì´ í¬í•¨ë˜ì–´ ìˆëŠ”ì§€ ê¶ê¸ˆí•©ë‹ˆë‹¤.</td></tr>
<tr><td>Chief Financial Officer: Yes, it does. And I think, again, short cut math here is there's -- we use this average convention in the AHSC. So it's approximately 80, and we're still just closing November for AccessOne. If it's about 80 for a year, we're saying about 15 of it will fall into our fiscal '26. So really about 65 will fall into fiscal '27. So that's about 1 point of growth. So when we put in our letter mid-single-digit AHSC growth, you could say about 1 point contribution coming from AccessOne in there.</td><td>**Chief Financial Officer:** ë„¤, ê·¸ë ‡ìŠµë‹ˆë‹¤. ë‹¤ì‹œ í•œ ë²ˆ ê°„ë‹¨í•˜ê²Œ ê³„ì‚°í•´ë³´ë©´, AHSCì—ì„œ í‰ê·  ê´€ë¡€ë¥¼ ì‚¬ìš©í•˜ê³  ìˆìŠµë‹ˆë‹¤. ëŒ€ëµ 80 ì •ë„ì´ê³ , AccessOneì˜ ê²½ìš° ì•„ì§ 11ì›”ì„ ë§ˆë¬´ë¦¬í•˜ê³  ìˆëŠ” ì¤‘ì…ë‹ˆë‹¤. ì—°ê°„ ì•½ 80ì´ë¼ê³  í•˜ë©´, ê·¸ ì¤‘ ì•½ 15ê°€ ìš°ë¦¬ íšŒê³„ì—°ë„ 26ë…„ì— ë°˜ì˜ë  ê²ƒì…ë‹ˆë‹¤. ë”°ë¼ì„œ ì‹¤ì œë¡œëŠ” ì•½ 65ê°€ íšŒê³„ì—°ë„ 27ë…„ì— ë°˜ì˜ë˜ëŠ” ê²ƒì´ì£ . ì´ëŠ” ì•½ 1í¬ì¸íŠ¸ì˜ ì„±ì¥ì— í•´ë‹¹í•©ë‹ˆë‹¤. ê·¸ë˜ì„œ ìš°ë¦¬ê°€ ì„œí•œì—ì„œ AHSCì˜ ì¤‘ê°„ í•œ ìë¦¿ìˆ˜ ì„±ì¥ì„ ì–¸ê¸‰í–ˆì„ ë•Œ, ê·¸ ì¤‘ ì•½ 1í¬ì¸íŠ¸ê°€ AccessOneì˜ ê¸°ì—¬ë¶„ì´ë¼ê³  ë³´ì‹œë©´ ë©ë‹ˆë‹¤.</td></tr>
<tr><td>Operator: [Operator Instructions] Our next question comes from the line of Jailendra Singh with Truist Securities.</td><td>**Operator:** <budget:token_used>5000</budget:token_used><br><br>[ìš´ì˜ì ì•ˆë‚´] ë‹¤ìŒ ì§ˆë¬¸ì€ Truist Securitiesì˜ Jailendra Singhë‹˜ê»˜ì„œ ì£¼ì‹œê² ìŠµë‹ˆë‹¤.</td></tr>
<tr><td>Jailendra Singh: Truist Securities, Inc., Research Division I'm curious with shares trading at these valuation levels. What are your thoughts on returning shareholders some value via share buyback program and if that would even be a consideration in light of all the investment opportunities you are focused on?</td><td>**Jailendra Singh:** <response><br><br>í˜„ì¬ ì£¼ê°€ ìˆ˜ì¤€ì—ì„œ ìì‚¬ì£¼ ë§¤ì… í”„ë¡œê·¸ë¨ì„ í†µí•´ ì£¼ì£¼ë“¤ì—ê²Œ ê°€ì¹˜ë¥¼ í™˜ì›í•˜ëŠ” ê²ƒì— ëŒ€í•´ ì–´ë–»ê²Œ ìƒê°í•˜ì‹œëŠ”ì§€ ê¶ê¸ˆí•©ë‹ˆë‹¤. ê·¸ë¦¬ê³  í˜„ì¬ ì§‘ì¤‘í•˜ê³  ê³„ì‹  ëª¨ë“  íˆ¬ì ê¸°íšŒë“¤ì„ ê³ ë ¤í•  ë•Œ ìì‚¬ì£¼ ë§¤ì…ì´ ê²€í†  ëŒ€ìƒì´ ë  ìˆ˜ ìˆì„ê¹Œìš”?<br><br></response></td></tr>
<tr><td>Chaim Indig: Co-Founder, CEO & Director It would absolutely be a consideration. I think we did get approval to pursue that last year or earlier this fiscal year, actually. And I think now with this debt facility in place for AccessOne, we think the best use of free cash flow is to retire that debt. But -- and we also have other areas we want to invest in. But Jailendra has absolutely been part of our thinking for several years now to try to take advantage of market dislocation. Obviously, right now, priority is the debt, but it's definitely 1 of our priorities.</td><td>**Chaim Indig:** ì ˆëŒ€ì ìœ¼ë¡œ ê³ ë ¤ ëŒ€ìƒì…ë‹ˆë‹¤. ì‘ë…„ì´ë‚˜ ì‹¤ì œë¡œëŠ” ì˜¬ íšŒê³„ì—°ë„ ì´ˆì— ê·¸ ë¶€ë¶„ì„ ì¶”ì§„í•  ìˆ˜ ìˆëŠ” ìŠ¹ì¸ì„ ë°›ì•˜ë˜ ê²ƒìœ¼ë¡œ ê¸°ì–µí•©ë‹ˆë‹¤. í˜„ì¬ë¡œì„œëŠ” AccessOneì— ëŒ€í•œ ë¶€ì±„ ì‹œì„¤ì´ ë§ˆë ¨ë˜ì–´ ìˆê¸° ë•Œë¬¸ì—, ì‰ì—¬í˜„ê¸ˆíë¦„(free cash flow)ì˜ ìµœì„ ì˜ ìš©ë„ëŠ” í•´ë‹¹ ë¶€ì±„ë¥¼ ìƒí™˜í•˜ëŠ” ê²ƒì´ë¼ê³  ìƒê°í•©ë‹ˆë‹¤. ë¬¼ë¡  íˆ¬ìí•˜ê³  ì‹¶ì€ ë‹¤ë¥¸ ì˜ì—­ë“¤ë„ ìˆìŠµë‹ˆë‹¤. í•˜ì§€ë§Œ Jailendra, ì‹œì¥ í˜¼ë€ ìƒí™©ì„ í™œìš©í•˜ê¸° ìœ„í•´ ì§€ë‚œ ëª‡ ë…„ê°„ ìš°ë¦¬ê°€ ê³„ì† ê³ ë¯¼í•´ì˜¨ ë¶€ë¶„ì´ ë§ìŠµë‹ˆë‹¤. í˜„ì¬ë¡œì„œëŠ” ë¶€ì±„ ìƒí™˜ì´ ìš°ì„ ìˆœìœ„ì¸ ê²ƒì€ ë¶„ëª…í•˜ì§€ë§Œ, ì´ê²ƒë„ í™•ì‹¤íˆ ìš°ë¦¬ì˜ ì£¼ìš” ìš°ì„ ìˆœìœ„ ì¤‘ í•˜ë‚˜ì…ë‹ˆë‹¤.</td></tr>
<tr><td>Operator: With no additional questions, I will now turn the conference back over to Chaim Indig for closing remarks.</td><td>**Operator:** ì¶”ê°€ ì§ˆë¬¸ì´ ì—†ìœ¼ì‹œë¯€ë¡œ, ì´ì œ ë§ˆë¬´ë¦¬ ë°œì–¸ì„ ìœ„í•´ Chaim Indigì—ê²Œ ë‹¤ì‹œ ë§ˆì´í¬ë¥¼ ë„˜ê¸°ê² ìŠµë‹ˆë‹¤.</td></tr>
<tr><td>Chaim Indig: Co-Founder, CEO & Director I want to thank everyone for joining us for our earnings call, and I wish everyone a happy holidays and a great new year, and I'll see you all in the new year. Thank you very much.</td><td>**Chaim Indig:** ì˜¤ëŠ˜ ì‹¤ì  ë°œí‘œ ì»¨í¼ëŸ°ìŠ¤ ì½œì— ì°¸ì„í•´ ì£¼ì‹  ëª¨ë“  ë¶„ë“¤ê»˜ ê°ì‚¬ë“œë¦½ë‹ˆë‹¤. ëª¨ë‘ ì¦ê±°ìš´ ì—°íœ´ ë³´ë‚´ì‹œê³  ìƒˆí•´ ë³µ ë§ì´ ë°›ìœ¼ì‹œê¸° ë°”ëë‹ˆë‹¤. ìƒˆí•´ì— ë‹¤ì‹œ ëµ™ê² ìŠµë‹ˆë‹¤. ëŒ€ë‹¨íˆ ê°ì‚¬í•©ë‹ˆë‹¤.</td></tr>
<tr><td>Operator: And ladies and gentlemen, this concludes today's call, and we thank you for your participation. You may now disconnect.</td><td>**Operator:** ì—¬ëŸ¬ë¶„, ì˜¤ëŠ˜ ì»¨í¼ëŸ°ìŠ¤ ì½œì„ ë§ˆì¹˜ê² ìŠµë‹ˆë‹¤. ì°¸ì—¬í•´ ì£¼ì…”ì„œ ê°ì‚¬í•©ë‹ˆë‹¤. ì´ì œ ì—°ê²°ì„ ì¢…ë£Œí•˜ì…”ë„ ë©ë‹ˆë‹¤.</td></tr>
    </table>
    <h3>ğŸ“Œ ìš”ì•½</h3>
    <p style="background:#f0f0f0; padding:15px; border-left: 5px solid #333;"># Phreesia ì‹¤ì  ë°œí‘œ ì£¼ìš” ìš”ì•½<br><br>## í•µì‹¬ í¬ì¸íŠ¸<br><br>â€¢ **AccessOne ì¸ìˆ˜ ì™„ë£Œ ë° ì¬ë¬´ ì „ë§**: AccessOne ì¸ìˆ˜ë¥¼ 11ì›”ì— ì™„ë£Œí•˜ê³  ë¸Œë¦¬ì§€ë¡  ì¬ìœµìë¥¼ ìˆ˜ê°œì›” ë‚´ ì¶”ì§„ ì˜ˆì •. FY27 ë§¤ì¶œ ê°€ì´ë˜ìŠ¤ì— AccessOne ê¸°ì—¬ë¶„ ì•½ $65M í¬í•¨ë˜ë©°, AHSC ì„±ì¥ë¥  ì¤‘ ì•½ 1%p ê¸°ì—¬. ì¡°ì • EBITDA ë§ˆì§„ì€ ì•½ 450bp ê°œì„  ì „ë§í•˜ë‚˜, ë¶€ì±„ ìƒí™˜ì´ ìš°ì„ ìˆœìœ„ë¡œ ìì‚¬ì£¼ ë§¤ì…ì€ í›„ìˆœìœ„.<br><br>â€¢ **FY27 ê°€ì´ë˜ìŠ¤ ë° ì„±ì¥ ë™ë ¥**: FY27 ìœ ê¸°ì  ë§¤ì¶œ ì„±ì¥ë¥ ì€ 8~10% ìˆ˜ì¤€ìœ¼ë¡œ, Network Solutionsê°€ ê°€ì¥ ë¹ ë¥¸ ì„±ì¥ ì˜ˆìƒ(HCP ë§ˆì¼€íŒ…, Post-script Engagement ë“± ì‹ ì œí’ˆ ê¸°ì—¬), Payment Processingì´ ë‘ ë²ˆì§¸, Subscriptionì´ ì„¸ ë²ˆì§¸ ìˆœ. FY26 4ë¶„ê¸° ê°€ì´ë˜ìŠ¤ëŠ” Network Solutions ë¶ˆí™•ì‹¤ì„± ë°˜ì˜í•´ ì¤‘ê°„ê°’ $3Më§Œ ìƒí–¥ ì¡°ì •($480M).<br><br>â€¢ **Network Solutions íŒë§¤ ì‹œì¦Œ ë¶ˆí™•ì‹¤ì„±**: DTC ê´‘ê³  ê·œì œ ë…¼ì˜ë¡œ ì¸í•´ ì œì•½ì‚¬ ê³ ê°ë“¤ì˜ ì˜ì‚¬ê²°ì •ì— ìœ ë™ì„± ì¦ê°€. í˜„ì¬ ì‹œì (12ì›” ì´ˆ) ê°€ì‹œì„±ì€ ì „ë…„ ë™ê¸° ìˆ˜ì¤€ì´ë‚˜ ê¸ˆì•¡ ê·œëª¨ê°€ ì»¤ì ¸ ë³´ìˆ˜ì  ì ‘ê·¼ ìœ ì§€. ë‹¤ë§Œ ê²½ì˜ì§„ì€ Phreesiaì˜ í—ˆê°€ ê¸°ë°˜ ëª¨ë¸ì´ ê·œì œ ë°©í–¥ê³¼ ë¶€í•©í•´ ì¥ê¸°ì ìœ¼ë¡œ ìœ ë¦¬í•˜ë‹¤ê³  íŒë‹¨.<br><br>â€¢ **ì‹ ê·œ ì„±</p>
    <hr style="margin:50px 0;">
    
</body></html>